Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors
Bladder cancer is a significant global health problem. Smoking and specific occupational exposures are the most established risk factors. There is emerging evidence for specific dietary factors, imbalanced microbiome, gene-external risk factor interactions, diesel exhaust emission exposure, and pelv...
Uložené v:
| Vydané v: | European urology Ročník 84; číslo 2; s. 176 - 190 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Switzerland
Elsevier B.V
01.08.2023
|
| Predmet: | |
| ISSN: | 0302-2838, 1873-7560, 1873-7560 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Bladder cancer is a significant global health problem. Smoking and specific occupational exposures are the most established risk factors. There is emerging evidence for specific dietary factors, imbalanced microbiome, gene-external risk factor interactions, diesel exhaust emission exposure, and pelvic radiotherapy.
Bladder cancer (BC) is common worldwide and poses a significant public health challenge. External risk factors and the wider exposome (totality of exposure from external and internal factors) contribute significantly to the development of BC. Therefore, establishing a clear understanding of these risk factors is the key to prevention.
To perform an up-to-date systematic review of BC's epidemiology and external risk factors.
Two reviewers (I.J. and S.O.) performed a systematic review using PubMed and Embase in January 2022 and updated it in September 2022. The search was restricted to 4 yr since our previous review in 2018.
Our search identified 5177 articles and a total of 349 full-text manuscripts. GLOBOCAN data from 2020 revealed an incidence of 573 000 new BC cases and 213 000 deaths worldwide in 2020. The 5-yr prevalence worldwide in 2020 was 1 721 000. Tobacco smoking and occupational exposures (aromatic amines and polycyclic aromatic hydrocarbons) are the most substantial risk factors. In addition, correlative evidence exists for several risk factors, including specific dietary factors, imbalanced microbiome, gene-environment risk factor interactions, diesel exhaust emission exposure, and pelvic radiotherapy.
We present a contemporary overview of the epidemiology of BC and the current evidence for BC risk factors. Smoking and specific occupational exposures are the most established risk factors. There is emerging evidence for specific dietary factors, imbalanced microbiome, gene-external risk factor interactions, diesel exhaust emission exposure, and pelvic radiotherapy. Further high-quality evidence is required to confirm initial findings and further understand cancer prevention.
Bladder cancer is common, and the most substantial risk factors are smoking and workplace exposure to suspected carcinogens. On-going research to identify avoidable risk factors could reduce the number of people who get bladder cancer. |
|---|---|
| AbstractList | Bladder cancer (BC) is common worldwide and poses a significant public health challenge. External risk factors and the wider exposome (totality of exposure from external and internal factors) contribute significantly to the development of BC. Therefore, establishing a clear understanding of these risk factors is the key to prevention.CONTEXTBladder cancer (BC) is common worldwide and poses a significant public health challenge. External risk factors and the wider exposome (totality of exposure from external and internal factors) contribute significantly to the development of BC. Therefore, establishing a clear understanding of these risk factors is the key to prevention.To perform an up-to-date systematic review of BC's epidemiology and external risk factors.OBJECTIVETo perform an up-to-date systematic review of BC's epidemiology and external risk factors.Two reviewers (I.J. and S.O.) performed a systematic review using PubMed and Embase in January 2022 and updated it in September 2022. The search was restricted to 4 yr since our previous review in 2018.EVIDENCE ACQUISITIONTwo reviewers (I.J. and S.O.) performed a systematic review using PubMed and Embase in January 2022 and updated it in September 2022. The search was restricted to 4 yr since our previous review in 2018.Our search identified 5177 articles and a total of 349 full-text manuscripts. GLOBOCAN data from 2020 revealed an incidence of 573 000 new BC cases and 213 000 deaths worldwide in 2020. The 5-yr prevalence worldwide in 2020 was 1 721 000. Tobacco smoking and occupational exposures (aromatic amines and polycyclic aromatic hydrocarbons) are the most substantial risk factors. In addition, correlative evidence exists for several risk factors, including specific dietary factors, imbalanced microbiome, gene-environment risk factor interactions, diesel exhaust emission exposure, and pelvic radiotherapy.EVIDENCE SYNTHESISOur search identified 5177 articles and a total of 349 full-text manuscripts. GLOBOCAN data from 2020 revealed an incidence of 573 000 new BC cases and 213 000 deaths worldwide in 2020. The 5-yr prevalence worldwide in 2020 was 1 721 000. Tobacco smoking and occupational exposures (aromatic amines and polycyclic aromatic hydrocarbons) are the most substantial risk factors. In addition, correlative evidence exists for several risk factors, including specific dietary factors, imbalanced microbiome, gene-environment risk factor interactions, diesel exhaust emission exposure, and pelvic radiotherapy.We present a contemporary overview of the epidemiology of BC and the current evidence for BC risk factors. Smoking and specific occupational exposures are the most established risk factors. There is emerging evidence for specific dietary factors, imbalanced microbiome, gene-external risk factor interactions, diesel exhaust emission exposure, and pelvic radiotherapy. Further high-quality evidence is required to confirm initial findings and further understand cancer prevention.CONCLUSIONSWe present a contemporary overview of the epidemiology of BC and the current evidence for BC risk factors. Smoking and specific occupational exposures are the most established risk factors. There is emerging evidence for specific dietary factors, imbalanced microbiome, gene-external risk factor interactions, diesel exhaust emission exposure, and pelvic radiotherapy. Further high-quality evidence is required to confirm initial findings and further understand cancer prevention.Bladder cancer is common, and the most substantial risk factors are smoking and workplace exposure to suspected carcinogens. On-going research to identify avoidable risk factors could reduce the number of people who get bladder cancer.PATIENT SUMMARYBladder cancer is common, and the most substantial risk factors are smoking and workplace exposure to suspected carcinogens. On-going research to identify avoidable risk factors could reduce the number of people who get bladder cancer. Bladder cancer (BC) is common worldwide and poses a significant public health challenge. External risk factors and the wider exposome (totality of exposure from external and internal factors) contribute significantly to the development of BC. Therefore, establishing a clear understanding of these risk factors is the key to prevention. To perform an up-to-date systematic review of BC's epidemiology and external risk factors. Two reviewers (I.J. and S.O.) performed a systematic review using PubMed and Embase in January 2022 and updated it in September 2022. The search was restricted to 4 yr since our previous review in 2018. Our search identified 5177 articles and a total of 349 full-text manuscripts. GLOBOCAN data from 2020 revealed an incidence of 573 000 new BC cases and 213 000 deaths worldwide in 2020. The 5-yr prevalence worldwide in 2020 was 1 721 000. Tobacco smoking and occupational exposures (aromatic amines and polycyclic aromatic hydrocarbons) are the most substantial risk factors. In addition, correlative evidence exists for several risk factors, including specific dietary factors, imbalanced microbiome, gene-environment risk factor interactions, diesel exhaust emission exposure, and pelvic radiotherapy. We present a contemporary overview of the epidemiology of BC and the current evidence for BC risk factors. Smoking and specific occupational exposures are the most established risk factors. There is emerging evidence for specific dietary factors, imbalanced microbiome, gene-external risk factor interactions, diesel exhaust emission exposure, and pelvic radiotherapy. Further high-quality evidence is required to confirm initial findings and further understand cancer prevention. Bladder cancer is common, and the most substantial risk factors are smoking and workplace exposure to suspected carcinogens. On-going research to identify avoidable risk factors could reduce the number of people who get bladder cancer. Bladder cancer is a significant global health problem. Smoking and specific occupational exposures are the most established risk factors. There is emerging evidence for specific dietary factors, imbalanced microbiome, gene-external risk factor interactions, diesel exhaust emission exposure, and pelvic radiotherapy. Bladder cancer (BC) is common worldwide and poses a significant public health challenge. External risk factors and the wider exposome (totality of exposure from external and internal factors) contribute significantly to the development of BC. Therefore, establishing a clear understanding of these risk factors is the key to prevention. To perform an up-to-date systematic review of BC's epidemiology and external risk factors. Two reviewers (I.J. and S.O.) performed a systematic review using PubMed and Embase in January 2022 and updated it in September 2022. The search was restricted to 4 yr since our previous review in 2018. Our search identified 5177 articles and a total of 349 full-text manuscripts. GLOBOCAN data from 2020 revealed an incidence of 573 000 new BC cases and 213 000 deaths worldwide in 2020. The 5-yr prevalence worldwide in 2020 was 1 721 000. Tobacco smoking and occupational exposures (aromatic amines and polycyclic aromatic hydrocarbons) are the most substantial risk factors. In addition, correlative evidence exists for several risk factors, including specific dietary factors, imbalanced microbiome, gene-environment risk factor interactions, diesel exhaust emission exposure, and pelvic radiotherapy. We present a contemporary overview of the epidemiology of BC and the current evidence for BC risk factors. Smoking and specific occupational exposures are the most established risk factors. There is emerging evidence for specific dietary factors, imbalanced microbiome, gene-external risk factor interactions, diesel exhaust emission exposure, and pelvic radiotherapy. Further high-quality evidence is required to confirm initial findings and further understand cancer prevention. Bladder cancer is common, and the most substantial risk factors are smoking and workplace exposure to suspected carcinogens. On-going research to identify avoidable risk factors could reduce the number of people who get bladder cancer. |
| Author | Bukavina, Laura Cumberbatch, Marcus G. Kiemeney, Lambertus Necchi, Andrea Lawrentschuk, Nathan Kamat, Ashish M. Lerner, Seth P. Moch, Holger Jubber, Ibrahim Black, Peter C. Sridhar, Srikala S. Ong, Sean Panebianco, Valeria Catto, James W.F. Znaor, Ariana Compérat, Eva Meeks, Joshua J. |
| Author_xml | – sequence: 1 givenname: Ibrahim surname: Jubber fullname: Jubber, Ibrahim email: i.jubber@sheffield.ac.uk organization: Academic Urology Unit, University of Sheffield, Sheffield, UK – sequence: 2 givenname: Sean surname: Ong fullname: Ong, Sean organization: EJ Whitten Foundation Prostate Cancer Research Centre, Epworth HealthCare, Melbourne, Australia – sequence: 3 givenname: Laura surname: Bukavina fullname: Bukavina, Laura organization: Fox Chase Cancer Center, Philadelphia, PA, USA – sequence: 4 givenname: Peter C. surname: Black fullname: Black, Peter C. organization: Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada – sequence: 5 givenname: Eva surname: Compérat fullname: Compérat, Eva organization: Department of Pathology, Medical University of Vienna, Vienna, Austria – sequence: 6 givenname: Ashish M. surname: Kamat fullname: Kamat, Ashish M. organization: Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA – sequence: 7 givenname: Lambertus surname: Kiemeney fullname: Kiemeney, Lambertus organization: Radboud University Medical Center, Nijmegen, The Netherlands – sequence: 8 givenname: Nathan surname: Lawrentschuk fullname: Lawrentschuk, Nathan organization: EJ Whitten Foundation Prostate Cancer Research Centre, Epworth HealthCare, Melbourne, Australia – sequence: 9 givenname: Seth P. surname: Lerner fullname: Lerner, Seth P. organization: Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA – sequence: 10 givenname: Joshua J. surname: Meeks fullname: Meeks, Joshua J. organization: Departments of Urology and Biochemistry, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA – sequence: 11 givenname: Holger surname: Moch fullname: Moch, Holger organization: Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland – sequence: 12 givenname: Andrea surname: Necchi fullname: Necchi, Andrea organization: Department of Medical Oncology, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy – sequence: 13 givenname: Valeria surname: Panebianco fullname: Panebianco, Valeria organization: Department of Radiological Sciences, Oncology, and Pathology, Sapienza University of Rome, Rome, Italy – sequence: 14 givenname: Srikala S. surname: Sridhar fullname: Sridhar, Srikala S. organization: Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada – sequence: 15 givenname: Ariana surname: Znaor fullname: Znaor, Ariana organization: Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France – sequence: 16 givenname: James W.F. surname: Catto fullname: Catto, James W.F. organization: Academic Urology Unit, University of Sheffield, Sheffield, UK – sequence: 17 givenname: Marcus G. surname: Cumberbatch fullname: Cumberbatch, Marcus G. organization: Academic Urology Unit, University of Sheffield, Sheffield, UK |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37198015$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkMtKxDAUhoMoOl7eQKRLNx1zaZtURBgHbygIXtYhk5xIxrYZk1aZtzfD6MbNwIGz-b-fc759tN35DhA6JnhMMKnO5mMYwhD8mGLKxjgNrbfQiAjOcl5WeBuNMMM0p4KJPbQf4xxjzMqa7aI9xkktMClH6OF64Qy0zjf-fZl5m101yhgI2VR1Oi3XZav-82ySvSxjD63qnc6e4cvB9yr-7OJHdqN070M8RDtWNRGOfvcBeru5fp3e5Y9Pt_fTyWOui4r0Oa-ErS3UBaWmFNXMGmNJwXhVlpDOM7TSGgCzGWdQ8xorS6Ayws6o5ga4ZgfodN27CP5zgNjL1kUNTaM68EOUVJCSFiJZStGT3-gwa8HIRXCtCkv5JyAFztcBHXyMAazUrk8_-q4PyjWSYLmyLedybVuubEichtYJLv7Bf_0bsMs1BklSEhlk1A6SbuMC6F4a7zYVXPwr0I3rnFbNByw34z9NDK58 |
| CitedBy_id | crossref_primary_10_20517_cdr_2025_95 crossref_primary_10_3389_fonc_2024_1495381 crossref_primary_10_1002_tox_24138 crossref_primary_10_1007_s11060_025_05039_4 crossref_primary_10_1016_j_asjsur_2024_07_312 crossref_primary_10_1038_s41585_024_00885_9 crossref_primary_10_1007_s00216_024_05595_0 crossref_primary_10_1111_jcmm_70410 crossref_primary_10_62347_ABZG4705 crossref_primary_10_1186_s12885_025_14641_8 crossref_primary_10_1038_s41598_025_88307_7 crossref_primary_10_1016_j_fjurol_2025_102935 crossref_primary_10_3389_fphar_2024_1380954 crossref_primary_10_3390_jcm12216845 crossref_primary_10_1016_j_acuroe_2024_03_003 crossref_primary_10_1016_j_canep_2025_102912 crossref_primary_10_1016_j_bpobgyn_2024_102536 crossref_primary_10_1016_j_acuro_2025_501789 crossref_primary_10_1080_07357907_2024_2363879 crossref_primary_10_1111_bju_16714 crossref_primary_10_1245_s10434_024_15559_4 crossref_primary_10_7759_cureus_82435 crossref_primary_10_3389_fonc_2024_1424293 crossref_primary_10_1007_s11033_024_09791_0 crossref_primary_10_1038_s41598_024_72918_7 crossref_primary_10_1136_rapm_2024_105949 crossref_primary_10_1200_EDBK_25_471924 crossref_primary_10_3390_cancers15235558 crossref_primary_10_18203_2349_3933_ijam20251942 crossref_primary_10_3390_jcm14010004 crossref_primary_10_1136_bmjopen_2023_076612 crossref_primary_10_3389_fonc_2024_1394451 crossref_primary_10_3390_biomedicines13040871 crossref_primary_10_1186_s40001_024_01920_6 crossref_primary_10_1007_s12672_025_02730_w crossref_primary_10_7124_bc_000B0E crossref_primary_10_1016_j_intimp_2025_114529 crossref_primary_10_4236_jbm_2025_134032 crossref_primary_10_1007_s00345_024_04949_8 crossref_primary_10_1016_j_intimp_2025_115057 crossref_primary_10_1016_j_tranon_2025_102528 crossref_primary_10_1177_03008916231221508 crossref_primary_10_1007_s10856_024_06786_y crossref_primary_10_1016_j_freeradbiomed_2024_11_001 crossref_primary_10_1097_JS9_0000000000002009 crossref_primary_10_1016_j_canep_2025_102817 crossref_primary_10_1007_s12672_025_02389_3 crossref_primary_10_1007_s40487_024_00266_7 crossref_primary_10_1038_s41598_025_02767_5 crossref_primary_10_1158_2159_8290_CD_24_0866 crossref_primary_10_1038_s41585_024_00935_2 crossref_primary_10_1016_j_humgen_2024_201312 crossref_primary_10_1080_10408347_2024_2373923 crossref_primary_10_1080_14737140_2025_2535657 crossref_primary_10_1007_s12094_025_04045_2 crossref_primary_10_1038_s41388_025_03311_5 crossref_primary_10_1016_j_radonc_2024_110595 crossref_primary_10_1080_14786419_2024_2373955 crossref_primary_10_1016_j_urology_2024_12_003 crossref_primary_10_1111_srt_13663 crossref_primary_10_18332_tid_204299 crossref_primary_10_1007_s00261_024_04748_0 crossref_primary_10_1002_ijc_70063 crossref_primary_10_1111_iwj_14793 crossref_primary_10_1038_s41416_025_03028_y crossref_primary_10_3390_ijms25126325 crossref_primary_10_3390_ijms251910388 crossref_primary_10_1097_MD_0000000000039412 crossref_primary_10_1016_j_apsb_2024_07_003 crossref_primary_10_1016_j_acuro_2025_501749 crossref_primary_10_1016_j_acuroe_2025_501789 crossref_primary_10_1016_j_urolonc_2025_03_014 crossref_primary_10_3390_toxics11090791 crossref_primary_10_53730_ijhs_v6nS10_14041 crossref_primary_10_1111_srt_13482 crossref_primary_10_1016_j_compbiolchem_2024_108149 crossref_primary_10_3892_wasj_2025_350 crossref_primary_10_1016_j_lanwpc_2025_101517 crossref_primary_10_1038_s41585_025_01072_0 crossref_primary_10_7759_cureus_84023 crossref_primary_10_1016_j_bbcan_2025_189454 crossref_primary_10_1016_j_phrs_2024_107302 crossref_primary_10_2147_IJWH_S543955 crossref_primary_10_1016_j_tranon_2024_102003 crossref_primary_10_3390_cancers16213653 crossref_primary_10_3322_caac_70019 crossref_primary_10_3390_cells13171463 crossref_primary_10_3390_medicina60122103 crossref_primary_10_1186_s13046_025_03495_4 crossref_primary_10_3389_fimmu_2025_1638628 crossref_primary_10_1111_bju_16242 crossref_primary_10_3390_cancers16173038 crossref_primary_10_1097_01_NURSE_0001007608_96581_fa crossref_primary_10_2340_sju_v60_44187 crossref_primary_10_3389_fimmu_2024_1486229 crossref_primary_10_3390_cancers17040713 crossref_primary_10_1038_s41598_024_79942_7 crossref_primary_10_3389_fimmu_2024_1493528 crossref_primary_10_1007_s10495_024_02065_x crossref_primary_10_1136_bmj_2023_076743 crossref_primary_10_1007_s12274_023_6051_x crossref_primary_10_1016_j_clgc_2024_102262 crossref_primary_10_1016_j_prp_2023_154673 crossref_primary_10_1038_s41388_025_03460_7 crossref_primary_10_3390_ijms25042178 crossref_primary_10_3892_ijmm_2023_5282 crossref_primary_10_1016_j_urolonc_2024_12_273 crossref_primary_10_1158_1940_6207_CAPR_24_0450 crossref_primary_10_1016_j_ccr_2025_216745 crossref_primary_10_1016_j_clgc_2024_102144 crossref_primary_10_1007_s12672_025_03397_z crossref_primary_10_1097_MS9_0000000000003399 crossref_primary_10_1016_j_intimp_2025_115301 crossref_primary_10_1159_000538373 crossref_primary_10_7717_peerj_18995 crossref_primary_10_3390_jpm13091418 crossref_primary_10_23736_S2724_6051_24_05876_2 crossref_primary_10_3390_diagnostics14050468 crossref_primary_10_1080_14786419_2024_2435536 crossref_primary_10_1186_s13062_024_00562_2 crossref_primary_10_3390_jpm14020158 crossref_primary_10_1007_s12033_024_01255_x crossref_primary_10_3390_cancers17020316 crossref_primary_10_1016_j_clinbiochem_2024_110780 crossref_primary_10_1016_j_heliyon_2024_e34114 crossref_primary_10_3390_cancers16030483 crossref_primary_10_1002_hsr2_71206 crossref_primary_10_1016_j_gene_2025_149772 crossref_primary_10_1093_postmj_qgae121 crossref_primary_10_3389_fimmu_2023_1258388 crossref_primary_10_1038_s41598_025_14615_7 crossref_primary_10_1177_03915603251360580 crossref_primary_10_1007_s12094_023_03270_x crossref_primary_10_1111_ajco_14191 crossref_primary_10_1016_j_biopha_2025_118108 crossref_primary_10_1007_s12032_025_02857_4 crossref_primary_10_1038_s41598_025_10413_3 crossref_primary_10_1016_j_bbrep_2025_102041 crossref_primary_10_1038_s41598_025_92297_x crossref_primary_10_3390_ijms26083595 crossref_primary_10_1016_j_compbiomed_2025_109980 crossref_primary_10_1038_s41598_023_47824_z crossref_primary_10_3892_ol_2024_14705 crossref_primary_10_1016_j_urolonc_2024_06_024 crossref_primary_10_1002_ddr_70128 crossref_primary_10_1016_j_apr_2025_102571 crossref_primary_10_1111_bju_16678 crossref_primary_10_1186_s13578_024_01210_y crossref_primary_10_1016_j_envres_2025_122589 crossref_primary_10_1093_toxres_tfae010 crossref_primary_10_1097_01_JAA_0000000000000235 crossref_primary_10_1186_s12967_023_04811_2 crossref_primary_10_1186_s12885_024_12632_9 crossref_primary_10_1016_j_acuroe_2025_501749 crossref_primary_10_1016_j_asjsur_2024_04_187 crossref_primary_10_1038_s41420_024_01883_x crossref_primary_10_1080_15384047_2025_2545057 crossref_primary_10_3390_medicina60091482 crossref_primary_10_1007_s12672_025_02165_3 crossref_primary_10_1177_23523735251370863 crossref_primary_10_1038_s41467_025_57633_9 crossref_primary_10_1038_s41591_024_03025_3 crossref_primary_10_3390_diagnostics15141749 crossref_primary_10_1007_s11255_025_04446_w crossref_primary_10_1186_s13244_024_01884_5 crossref_primary_10_1001_jamanetworkopen_2025_14427 crossref_primary_10_1016_j_urolonc_2024_10_014 crossref_primary_10_1186_s12935_025_03766_2 crossref_primary_10_3390_uro4030012 crossref_primary_10_1097_JU9_0000000000000145 crossref_primary_10_1177_10732748241302957 crossref_primary_10_1186_s13072_024_00554_6 crossref_primary_10_1016_j_jhazmat_2025_137833 crossref_primary_10_1136_jitc_2025_011881 crossref_primary_10_7759_cureus_69637 crossref_primary_10_1093_occmed_kqaf089 crossref_primary_10_4236_oju_2025_156020 crossref_primary_10_2147_RRU_S530209 crossref_primary_10_3390_biom13101498 crossref_primary_10_1016_j_heliyon_2024_e34029 crossref_primary_10_1002_adma_202511181 crossref_primary_10_1016_j_acuro_2024_03_001 crossref_primary_10_3390_cancers17132262 crossref_primary_10_1007_s00204_024_03737_y crossref_primary_10_1016_j_urolonc_2025_01_007 crossref_primary_10_5812_ijpr_153408 crossref_primary_10_1002_2056_4538_12363 crossref_primary_10_1007_s11701_025_02379_1 crossref_primary_10_1016_j_ecoenv_2025_119037 crossref_primary_10_1515_med_2024_1069 crossref_primary_10_3390_cancers17020169 crossref_primary_10_1097_RLI_0000000000001099 crossref_primary_10_1038_s41598_025_96892_w crossref_primary_10_1016_j_lfs_2024_122609 crossref_primary_10_1038_s41598_025_89008_x crossref_primary_10_1007_s00345_025_05583_8 crossref_primary_10_1080_15257770_2024_2310710 crossref_primary_10_3390_diagnostics15010059 crossref_primary_10_1016_j_eucr_2025_102997 crossref_primary_10_1016_j_urolonc_2025_05_008 crossref_primary_10_3390_jcm14134492 crossref_primary_10_3390_cancers17010110 crossref_primary_10_1038_s12276_024_01377_x crossref_primary_10_1007_s11912_024_01524_7 crossref_primary_10_1016_j_taap_2024_116878 crossref_primary_10_1111_iju_15638 crossref_primary_10_1016_j_critrevonc_2025_104769 crossref_primary_10_18332_tid_204744 crossref_primary_10_3390_jpm14040392 crossref_primary_10_1016_j_bcp_2025_116903 crossref_primary_10_1186_s12889_024_18353_9 crossref_primary_10_3390_plants13071047 crossref_primary_10_1038_s41598_024_70379_6 crossref_primary_10_1111_bju_16516 crossref_primary_10_1186_s12885_025_14132_w crossref_primary_10_3389_fphar_2024_1503154 crossref_primary_10_3390_ijerph21121633 crossref_primary_10_1007_s10654_024_01100_0 crossref_primary_10_3390_biomedicines12081832 crossref_primary_10_1002_biof_2150 crossref_primary_10_1007_s40273_024_01463_y crossref_primary_10_1155_jdr_1271189 crossref_primary_10_1002_cam4_70242 crossref_primary_10_7759_cureus_89796 crossref_primary_10_2147_JIR_S487740 crossref_primary_10_4103_JCOT_JCOT_4_25 crossref_primary_10_1002_kjm2_12821 crossref_primary_10_1007_s00210_025_04189_6 crossref_primary_10_1016_j_lfs_2025_123632 crossref_primary_10_1016_j_intimp_2024_111613 crossref_primary_10_3390_cancers17132210 crossref_primary_10_1016_j_intimp_2024_113232 crossref_primary_10_17650_1726_9776_2024_20_2_148_156 crossref_primary_10_3389_fonc_2024_1463173 crossref_primary_10_1080_14786419_2025_2524610 crossref_primary_10_1002_adma_202502452 crossref_primary_10_1039_D4FO05538A crossref_primary_10_1016_j_critrevonc_2025_104862 crossref_primary_10_17650_1726_9776_2025_21_1_71_83 crossref_primary_10_1186_s12967_025_06518_y crossref_primary_10_3389_fonc_2024_1352065 crossref_primary_10_1016_j_tox_2025_154193 crossref_primary_10_1111_ans_70175 crossref_primary_10_3390_cancers17162663 crossref_primary_10_1016_j_euo_2023_09_021 crossref_primary_10_58240_1829006X_2025_21_7_68 crossref_primary_10_1186_s12943_024_02095_8 crossref_primary_10_7759_cureus_87583 crossref_primary_10_1038_s41417_024_00784_6 crossref_primary_10_1016_j_fpurol_2024_07_209 crossref_primary_10_1136_oemed_2024_109549 crossref_primary_10_3390_curroncol32070394 crossref_primary_10_1016_j_asjsur_2024_05_076 crossref_primary_10_1038_s41585_024_00859_x crossref_primary_10_7759_cureus_90077 crossref_primary_10_3390_cancers16010131 crossref_primary_10_1155_2024_2699706 crossref_primary_10_1080_14737140_2025_2548487 |
| Cites_doi | 10.1002/ijc.33042 10.1007/s00345-018-2216-8 10.21037/tau-20-1020 10.1016/j.euo.2023.02.004 10.1016/j.euo.2020.02.004 10.3390/nu13113927 10.1002/cam4.5132 10.1093/ajcn/88.4.1083 10.1186/s12916-021-01931-8 10.3904/kjim.2017.402 10.18632/oncotarget.24724 10.1007/s00345-018-2257-z 10.1007/s00345-019-02825-4 10.1038/s41430-019-0453-6 10.1001/jama.2011.1142 10.1016/j.watres.2022.118202 10.1158/1940-6207.CAPR-18-0441 10.1016/j.gene.2019.144077 10.1016/S2214-109X(20)30059-0 10.1002/ijc.32420 10.1200/JCO.2019.37.7_suppl.423 10.1002/ijc.33588 10.1371/journal.pone.0222875 10.1038/s41416-022-01735-4 10.1007/s10654-021-00762-4 10.1073/pnas.2117904119 10.1016/j.gene.2020.144924 10.1007/s11255-020-02659-9 10.1097/CEJ.0000000000000419 10.3389/fcimb.2018.00167 10.1038/s41416-018-0029-6 10.1002/ijc.33008 10.1097/MD.0000000000011596 10.1016/j.urolonc.2018.03.020 10.1001/jama.2018.4658 10.1001/jamaoncol.2015.3209 10.1038/s41416-020-01101-2 10.1097/JU.0000000000001694 10.1002/ijc.33173 10.3389/fcimb.2020.555508 10.1038/s41598-018-29054-w 10.1111/ane.13299 10.1007/s10654-019-00597-0 10.3904/kjim.2020.259 10.1016/j.eururo.2018.09.034 10.1016/j.clgc.2022.08.009 10.1016/S0140-6736(15)60264-1 10.3390/medicina56090441 10.1200/JCO.20.01665 10.1007/s00345-020-03077-3 10.18632/aging.102699 10.1016/S0140-6736(22)01188-6 10.1038/s41416-022-01718-5 10.1111/bju.13345 10.1007/s00345-019-02690-1 10.1016/j.eururo.2012.07.033 10.1111/bju.14841 10.1186/s12885-018-5014-1 10.1038/s41585-022-00611-3 10.1002/ijc.32083 10.2147/CMAR.S175062 10.1016/j.clnu.2022.03.020 10.1093/ajcn/nqaa215 10.1016/j.puhe.2021.11.019 10.1016/j.semarthrit.2021.03.014 10.1007/s10147-019-01427-9 10.1136/bmjopen-2021-050728 10.14309/ajg.0000000000001310 10.1080/01635581.2018.1512636 10.1016/j.urolonc.2020.04.028 10.1002/cam4.1354 10.2147/CMAR.S185867 10.1111/dom.13745 10.1038/s41598-017-19030-1 10.1016/j.jsbmb.2019.01.002 10.1016/j.transproceed.2018.02.146 10.1016/j.canep.2020.101707 10.1038/nature09944 10.1002/ijc.33311 10.1080/0284186X.2018.1518591 10.1007/s00394-019-01907-8 10.1093/toxsci/kfaa087 10.21037/tau-20-1358 10.1177/1559325819863634 10.1016/S0022-5347(05)64362-5 10.1038/s41467-020-19971-8 10.1002/ijc.32199 10.1097/JU.0000000000000279 10.1016/j.clinre.2020.07.019 10.1016/j.eururo.2020.03.055 10.1016/j.eururo.2018.09.001 10.17269/s41997-019-00227-y 10.1016/j.euf.2014.10.001 10.1016/j.cegh.2017.08.002 10.1002/ijc.31597 10.1016/j.ccell.2020.04.012 10.34172/aim.2020.72 10.1016/j.envint.2019.105346 10.1002/nau.23457 10.4178/epih.e2022050 10.1016/j.eururo.2018.12.043 10.1007/s00240-017-1033-7 10.1007/s11255-022-03173-w 10.1007/s00394-022-02805-2 10.1016/j.eururo.2021.12.004 10.1016/j.eururo.2020.09.006 10.1038/s41416-019-0392-y 10.1080/13685538.2019.1646238 10.1002/ijc.32136 10.1136/bmjgh-2020-004128 10.1038/s41591-022-02014-8 |
| ContentType | Journal Article |
| Copyright | 2023 The Author(s) Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2023 The Author(s) – notice: Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved. |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.eururo.2023.03.029 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1873-7560 |
| EndPage | 190 |
| ExternalDocumentID | 37198015 10_1016_j_eururo_2023_03_029 S0302283823027070 |
| Genre | Systematic Review Journal Article |
| GrantInformation_xml | – fundername: World Health Organization grantid: 001 |
| GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 0~B 1B1 1P~ 1~. 1~5 29G 30W 34G 39C 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 8UI AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYIC AAYWO ABBQC ABBTS ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABWCG ABWVN ABXDB ACDAQ ACIEU ACLOT ACQXL ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AEYAO AFJKZ AFPUW AFRHN AFSIO AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BLXMC BNPGV CAG COF CS3 CYUIP DU5 E0A EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FB. FDB FEDTE FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O1H O9- OAUVE OK. OW. OZT P-8 P-9 P2P PC. Q38 RKO ROL RPZ SCC SDF SDG SEL SES SEW SPCBC SSH SSZ T5K UDS UJ6 UV1 X7M Z5R ZGI ZXP ~G- ~HD 6I. AACTN AAFTH AAIAV ABLVK ABYKQ AFCTW AFKWA AHPSJ AJBFU AJOXV AMFUW AZPMC LCYCR RIG ZA5 9DU AAYXX CITATION AGCQF AGRNS CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c461t-768f9fe9422d586bfddf1437655e593d26ccee03b73e9790af1e6d8fb2c7de7c3 |
| ISICitedReferencesCount | 291 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001043019600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0302-2838 1873-7560 |
| IngestDate | Sun Nov 09 14:13:54 EST 2025 Mon Jul 21 05:57:40 EDT 2025 Sat Nov 29 07:19:46 EST 2025 Tue Nov 18 22:30:35 EST 2025 Fri Feb 23 02:35:10 EST 2024 Tue Oct 14 19:29:28 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Prevalence Bladder cancer Epidemiology Risk factors Incidence |
| Language | English |
| License | This is an open access article under the CC BY license. Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c461t-768f9fe9422d586bfddf1437655e593d26ccee03b73e9790af1e6d8fb2c7de7c3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 ObjectType-Review-4 content type line 23 |
| OpenAccessLink | https://dx.doi.org/10.1016/j.eururo.2023.03.029 |
| PMID | 37198015 |
| PQID | 2815248101 |
| PQPubID | 23479 |
| PageCount | 15 |
| ParticipantIDs | proquest_miscellaneous_2815248101 pubmed_primary_37198015 crossref_citationtrail_10_1016_j_eururo_2023_03_029 crossref_primary_10_1016_j_eururo_2023_03_029 elsevier_sciencedirect_doi_10_1016_j_eururo_2023_03_029 elsevier_clinicalkey_doi_10_1016_j_eururo_2023_03_029 |
| PublicationCentury | 2000 |
| PublicationDate | August 2023 2023-08-00 20230801 |
| PublicationDateYYYYMMDD | 2023-08-01 |
| PublicationDate_xml | – month: 08 year: 2023 text: August 2023 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | European urology |
| PublicationTitleAlternate | Eur Urol |
| PublicationYear | 2023 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Larsson, Andersson, Johansson, Wolk (b0220) 2008; 88 Arumugam, Raes, Pelletier (b0420) 2011; 473 Fang, Liao, Wu, Muo (b0450) 2018; 36 Dianatinasab, Wesselius, de Loeij (b0230) 2021; 36 Catto, Gordon, Collinson (b0010) 2021; 39 Song, Jin, Chen, Liang, Liu (b0360) 2020; 177 Choi, Kim, Hong, Han, Ha (b0490) 2019; 37 Santella, Rouette, Brundage, Filion, Azoulay (b0620) 2020; 38 Li, Zhu, Wu (b0565) 2021; 53 Yu, Yue, Jiuzhi, Youtao, Guofei, Wenbin (b0445) 2018; 46 Huang, Huang, Ruan (b0150) 2023; 12 Dunn, Jefferson, MacDonald, Iqbal, Bland (b0250) 2019; 188 Boffetta, Borron (b0265) 2019; 17 Cardwell, McDowell, Hughes, Hicks, Murchie (b0580) 2021; 116 Song, Kim, Naskar (b0405) 2022; 119 Helte, Save-Soderbergh, Ugge, Fall, Larsson, Akesson (b0295) 2022; 214 Li, Tindle, Hendryx (b0130) 2019; 12 Chen, Rodopoulou, Strak (b0280) 2022; 126 Vartolomei, Iwata, Roth (b0200) 2019; 37 Zeng, Zhang, Chen (b0390) 2020; 10 Yeo, Seo, Hwang, Shim (b0530) 2020; 23 Feng, Yang, Wang, Wei, Li (b0545) 2021; 10 Zhang, Liu, Peng (b0550) 2021; 10 Hu, Chen, Cui (b0600) 2018; 97 Mazzone, Mistretta, Knipper (b0475) 2019; 124 Zhang, Birmann, Han (b0300) 2020; 370 Seow, Rahmat, Mohamed, Mahendran, Lee, Bay (b0400) 2002; 168 . Boot, Wesselius, Yu (b0255) 2022; 61 Teleka, Haggstrom, Nagel (b0495) 2018; 143 Moschini, Zaffuto, Karakiewicz (b0465) 2019; 75 Tang, Shi, Fu (b0570) 2018; 7 Ramirez, Gupta, Canter (b0020) 2016; 117 Hird, Saskin, Liu (b0440) 2021; 11 Mossanen, Carvalho, Muralidhar (b0480) 2022; 81 Carrot-Zhang, Chambwe, Damrauer (b0310) 2020; 37 Kim, Kim, Ahn (b0625) 2020; 23 Zhou, Li, Xie, Zhong, Zhong, Lin (b0350) 2018; 18 Yu, Wesselius, Mehrkanoon (b0190) 2020; 112 Choi, Ahn, Lee, Moon (b0535) 2021; 51 IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some drinking-water disinfectants and contaminants, including arsenic. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 84. International Agency for Research on Cancer; 2004. Santucci, Gallus, Martinetti, La Vecchia, Bosetti (b0605) 2021; 148 Al-Zalabani, Wesselius, Yi-Wen (b0215) 2022; 41 Vosoughi, Zhang, Shohdy (b0100) 2020; 11 Laaksonen, MacInnis, Canfell (b0120) 2020; 146 Bilano, Gilmour, Moffiet (b0030) 2015; 385 Kim, Yoo, Min, Choi (b0335) 2021; 13 Cumberbatch, Jubber, Black (b0055) 2018; 74 Witjes, Bruins, Cathomas (b0015) 2021; 79 Roser M, Ritchie H. Cancer. Our world in data. July 2015. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Outdoor air pollution. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 109. International Agency for Research on Cancer; 2015. Koutros, Kogevinas, Friesen (b0275) 2020; 135 Mossanen, Nassar, Stokes (b0095) 2022; 20 Zhao, Xie, Yang (b0470) 2019; 11 Burger, Catto, Dalbagni (b0050) 2013; 63 Zhu, Srivastava, Agalliu (b0635) 2021; 206 Song, Qi, Liu (b0340) 2020; 757 Bukavina L, Isali I, Ginwala R, et al. Global meta-analysis of urine microbiome: colonization of PAH-degrading bacteria among bladder cancer patients. Eur Urol Oncol. In press. Bray, Ferlay, Soerjomataram, Siegel, Torre, Jemal (b0005) 2018; 68 Kim, Jang, Kim (b0515) 2020; 35 Cumberbatch, Cox, Teare, Catto (b0045) 2015; 1 Page, McKenzie, Bossuyt (b0060) 2021; 372 Wandell, Carlsson, Li, Sundquist, Sundquist (b0585) 2020; 66 Bothig, Tiburtius, Fiebag (b0430) 2020; 38 International Agency for Research on Cancer. List of classifications by cancer sites with sufficient or limited evidence in humans. IARC monographs volumes 1–132. July 1, 2022. Song, Chen, Liu (b0355) 2019; 719 Turner, Gracia-Lavedan, Cirac (b0285) 2019; 145 Markowski, Boorjian, Burton (b0375) 2019; 75 Safiri, Kolahi, Naghavi, Global Burden of Disease Bladder Cancer Collaborators (b0085) 2021; 6 Yu, Wesselius, Mehrkanoon (b0240) 2021; 19 Chen, Zhernakova, Kurilshikov (b0345) 2022; 28 Guercio, Turati, Bosetti (b0615) 2019; 28 He, Li, Huang (b0410) 2020; 29 Feng, Shao, Ju, Zhang (b0525) 2021 Teoh, Huang, Ko (b0315) 2020; 78 Hadkhale, Martinsen, Weiderpass (b0165) 2019; 58 Tsoi, Ho, Chan, Sung (b0610) 2019; 145 Sweis R, Golan S, Barashi N, et al. Association of the commensal urinary microbiome with response to bacillus Calmette-Guérin (BCG) immunotherapy in nonmuscle invasive bladder cancer. Presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium; February 14–16, 2019; San Francisco, CA, USA. Wu, Zhang, Zhao (b0365) 2018; 8 Fuller, Acharya, Meyyappan (b0140) 2018; 8 Martin, Woolbright, Umar, Ingersoll, Taylor (b0385) 2022; 19 Adil, Khan, Ghosh, Venkata, Kandhare, Sharma (b0575) 2018; 6 Wen, Zhong, Zhang, Zhong (b0485) 2022; 22 Sathianathen, Fan, Jarosek, Lawrentschuk, Konety (b0630) 2018; 36 Altieri, Seree, Lobbedez (b0560) 2021; 45 Fang, Hsieh, Huang, Tsai, Muo, Wu (b0455) 2019; 14 Abufaraj, Tabung, Shariat (b0245) 2019; 202 Oh, Lee, Lee (b0540) 2022; 37 Hong, Xu, Lan (b0205) 2018; 70 Ismail, Karsenty, Chartier-Kastler (b0435) 2018; 37 Xie, Xu, Wang (b0590) 2020; 12 Jalilian, Ziaei, Weiderpass, Rueegg, Khosravi, Kjaerheim (b0170) 2019; 145 Bao, Xu, Lu, Snetselaar, Wallace (b0040) 2018; 319 Delon, Brown, Payne, Kotrotsios, Vernon, Shelton (b0305) 2022; 126 Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer; 2020. Li, Hendryx, Xun (b0510) 2020; 31 Tybjerg, Babore, Olsen, Andersen (b0520) 2020; 142 Pan, Lee, Lee (b0505) 2020; 56 Sarich, Canfell, Egger (b0195) 2021; 124 Ahmadinezhad, Arshadi, Hesari, Sharafoddin, Azizi, Khodamoradi (b0500) 2022; 44 Ihira, Sawada, Yamaji (b0330) 2019; 120 Bjurlin, Matulewicz, Roberts (b0145) 2021; 4 Freedman, Silverman, Hollenbeck, Schatzkin, Abnet (b0110) 2011; 306 Yu, Dai, Wesselius (b0210) 2020; 35 Comperat, Amin, Cathomas (b0025) 2022; 400 Sung, Ferlay, Siegel (b0070) 2021; 71 Acham, Wesselius, van Osch (b0225) 2020; 74 Densmore, Hajizadeh, Hu (b0320) 2019; 110 Jacob, Freyn, Kalder, Dinas, Kostev (b0115) 2018; 9 Yan, Ying, Xie (b0135) 2018; 10 Witlox, van Osch, Brinkman (b0180) 2020; 59 Bayne, Farah, Herbst, Hsieh (b0425) 2018; 36 Dianatinasab, Wesselius, Salehi-Abargouei (b0185) 2020; 147 Ferlay, Colombet, Soerjomataram (b0075) 2021; 149 Ferlay J, Laversanne M, Ervik M, et al. Global cancer observatory: cancer tomorrow. Lyon, France: International Agency for Research on Cancer; 2020. Zhao, Wang, Liang (b0125) 2022; 54 Bukavina L, Calaway A, Isali I, et al. Characterization and functional analysis of microbiome in bladder cancer. Presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium; February 17–19, 2022; San Francisco, CA, USA. Jochems, Reulen, van Osch (b0235) 2020; 147 Islami, Stoklosa, Drope, Jemal (b0035) 2015; 1 Bucevic Popovic, Situm, Chow, Chan, Roje, Terzic (b0370) 2018; 8 Arafa, Ewis, Eshak (b0290) 2022; 203 Dicembrini, Nreu, Mannucci, Monami (b0595) 2019; 21 Brown, Rumgay, Dunlop (b0160) 2018; 118 Li, Hendryx, Xun (b0325) 2020; 147 Sheikh, Shakeri, Poustchi (b0155) 2020; 8 Guo, Liu, Hou (b0460) 2019; 24 Lizakowski, Kolonko, Imko-Walczuk (b0555) 2018; 50 World Cancer Research Fund/American Institute for Cancer Research. Diet, nutrition, physical activity and bladder cancer. Continuous update project expert report. 2015. Jalilian (10.1016/j.eururo.2023.03.029_b0170) 2019; 145 Guo (10.1016/j.eururo.2023.03.029_b0460) 2019; 24 Witjes (10.1016/j.eururo.2023.03.029_b0015) 2021; 79 Abufaraj (10.1016/j.eururo.2023.03.029_b0245) 2019; 202 Teoh (10.1016/j.eururo.2023.03.029_b0315) 2020; 78 Li (10.1016/j.eururo.2023.03.029_b0325) 2020; 147 Bjurlin (10.1016/j.eururo.2023.03.029_b0145) 2021; 4 10.1016/j.eururo.2023.03.029_b0415 Oh (10.1016/j.eururo.2023.03.029_b0540) 2022; 37 Xie (10.1016/j.eururo.2023.03.029_b0590) 2020; 12 Li (10.1016/j.eururo.2023.03.029_b0565) 2021; 53 10.1016/j.eururo.2023.03.029_b0260 Arafa (10.1016/j.eururo.2023.03.029_b0290) 2022; 203 Song (10.1016/j.eururo.2023.03.029_b0355) 2019; 719 Yeo (10.1016/j.eururo.2023.03.029_b0530) 2020; 23 10.1016/j.eururo.2023.03.029_b0380 Fang (10.1016/j.eururo.2023.03.029_b0455) 2019; 14 Bao (10.1016/j.eururo.2023.03.029_b0040) 2018; 319 Tybjerg (10.1016/j.eururo.2023.03.029_b0520) 2020; 142 Vosoughi (10.1016/j.eururo.2023.03.029_b0100) 2020; 11 Carrot-Zhang (10.1016/j.eururo.2023.03.029_b0310) 2020; 37 Wu (10.1016/j.eururo.2023.03.029_b0365) 2018; 8 Choi (10.1016/j.eururo.2023.03.029_b0535) 2021; 51 Dianatinasab (10.1016/j.eururo.2023.03.029_b0185) 2020; 147 Feng (10.1016/j.eururo.2023.03.029_b0525) 2021 Wen (10.1016/j.eururo.2023.03.029_b0485) 2022; 22 Mossanen (10.1016/j.eururo.2023.03.029_b0480) 2022; 81 Jochems (10.1016/j.eururo.2023.03.029_b0235) 2020; 147 10.1016/j.eururo.2023.03.029_b0395 Seow (10.1016/j.eururo.2023.03.029_b0400) 2002; 168 Boffetta (10.1016/j.eururo.2023.03.029_b0265) 2019; 17 Li (10.1016/j.eururo.2023.03.029_b0130) 2019; 12 10.1016/j.eururo.2023.03.029_b0270 Yu (10.1016/j.eururo.2023.03.029_b0445) 2018; 46 Song (10.1016/j.eururo.2023.03.029_b0360) 2020; 177 Zeng (10.1016/j.eururo.2023.03.029_b0390) 2020; 10 Ahmadinezhad (10.1016/j.eururo.2023.03.029_b0500) 2022; 44 Wandell (10.1016/j.eururo.2023.03.029_b0585) 2020; 66 Zhang (10.1016/j.eururo.2023.03.029_b0300) 2020; 370 Hong (10.1016/j.eururo.2023.03.029_b0205) 2018; 70 Martin (10.1016/j.eururo.2023.03.029_b0385) 2022; 19 Comperat (10.1016/j.eururo.2023.03.029_b0025) 2022; 400 Chen (10.1016/j.eururo.2023.03.029_b0345) 2022; 28 Kim (10.1016/j.eururo.2023.03.029_b0335) 2021; 13 10.1016/j.eururo.2023.03.029_b0080 Turner (10.1016/j.eururo.2023.03.029_b0285) 2019; 145 Helte (10.1016/j.eururo.2023.03.029_b0295) 2022; 214 Page (10.1016/j.eururo.2023.03.029_b0060) 2021; 372 Chen (10.1016/j.eururo.2023.03.029_b0280) 2022; 126 Bayne (10.1016/j.eururo.2023.03.029_b0425) 2018; 36 Bucevic Popovic (10.1016/j.eururo.2023.03.029_b0370) 2018; 8 Witlox (10.1016/j.eururo.2023.03.029_b0180) 2020; 59 Dunn (10.1016/j.eururo.2023.03.029_b0250) 2019; 188 Choi (10.1016/j.eururo.2023.03.029_b0490) 2019; 37 Adil (10.1016/j.eururo.2023.03.029_b0575) 2018; 6 Feng (10.1016/j.eururo.2023.03.029_b0545) 2021; 10 Yu (10.1016/j.eururo.2023.03.029_b0210) 2020; 35 Pan (10.1016/j.eururo.2023.03.029_b0505) 2020; 56 Sarich (10.1016/j.eururo.2023.03.029_b0195) 2021; 124 Al-Zalabani (10.1016/j.eururo.2023.03.029_b0215) 2022; 41 Huang (10.1016/j.eururo.2023.03.029_b0150) 2023; 12 Markowski (10.1016/j.eururo.2023.03.029_b0375) 2019; 75 Burger (10.1016/j.eururo.2023.03.029_b0050) 2013; 63 10.1016/j.eururo.2023.03.029_b0090 Jacob (10.1016/j.eururo.2023.03.029_b0115) 2018; 9 Song (10.1016/j.eururo.2023.03.029_b0340) 2020; 757 He (10.1016/j.eururo.2023.03.029_b0410) 2020; 29 Delon (10.1016/j.eururo.2023.03.029_b0305) 2022; 126 Hird (10.1016/j.eururo.2023.03.029_b0440) 2021; 11 Moschini (10.1016/j.eururo.2023.03.029_b0465) 2019; 75 Dicembrini (10.1016/j.eururo.2023.03.029_b0595) 2019; 21 Vartolomei (10.1016/j.eururo.2023.03.029_b0200) 2019; 37 Fuller (10.1016/j.eururo.2023.03.029_b0140) 2018; 8 Arumugam (10.1016/j.eururo.2023.03.029_b0420) 2011; 473 Li (10.1016/j.eururo.2023.03.029_b0510) 2020; 31 10.1016/j.eururo.2023.03.029_b0065 Catto (10.1016/j.eururo.2023.03.029_b0010) 2021; 39 Larsson (10.1016/j.eururo.2023.03.029_b0220) 2008; 88 Safiri (10.1016/j.eururo.2023.03.029_b0085) 2021; 6 Sheikh (10.1016/j.eururo.2023.03.029_b0155) 2020; 8 Guercio (10.1016/j.eururo.2023.03.029_b0615) 2019; 28 Ferlay (10.1016/j.eururo.2023.03.029_b0075) 2021; 149 Tsoi (10.1016/j.eururo.2023.03.029_b0610) 2019; 145 Zhang (10.1016/j.eururo.2023.03.029_b0550) 2021; 10 Zhou (10.1016/j.eururo.2023.03.029_b0350) 2018; 18 Islami (10.1016/j.eururo.2023.03.029_b0035) 2015; 1 Bothig (10.1016/j.eururo.2023.03.029_b0430) 2020; 38 Mossanen (10.1016/j.eururo.2023.03.029_b0095) 2022; 20 10.1016/j.eururo.2023.03.029_b0105 Zhao (10.1016/j.eururo.2023.03.029_b0470) 2019; 11 Yu (10.1016/j.eururo.2023.03.029_b0190) 2020; 112 Densmore (10.1016/j.eururo.2023.03.029_b0320) 2019; 110 Santella (10.1016/j.eururo.2023.03.029_b0620) 2020; 38 Teleka (10.1016/j.eururo.2023.03.029_b0495) 2018; 143 Cumberbatch (10.1016/j.eururo.2023.03.029_b0055) 2018; 74 Koutros (10.1016/j.eururo.2023.03.029_b0275) 2020; 135 Mazzone (10.1016/j.eururo.2023.03.029_b0475) 2019; 124 Dianatinasab (10.1016/j.eururo.2023.03.029_b0230) 2021; 36 Altieri (10.1016/j.eururo.2023.03.029_b0560) 2021; 45 Yan (10.1016/j.eururo.2023.03.029_b0135) 2018; 10 Laaksonen (10.1016/j.eururo.2023.03.029_b0120) 2020; 146 Song (10.1016/j.eururo.2023.03.029_b0405) 2022; 119 Boot (10.1016/j.eururo.2023.03.029_b0255) 2022; 61 Kim (10.1016/j.eururo.2023.03.029_b0515) 2020; 35 Bray (10.1016/j.eururo.2023.03.029_b0005) 2018; 68 Bilano (10.1016/j.eururo.2023.03.029_b0030) 2015; 385 Kim (10.1016/j.eururo.2023.03.029_b0625) 2020; 23 Yu (10.1016/j.eururo.2023.03.029_b0240) 2021; 19 Hu (10.1016/j.eururo.2023.03.029_b0600) 2018; 97 Ismail (10.1016/j.eururo.2023.03.029_b0435) 2018; 37 Zhu (10.1016/j.eururo.2023.03.029_b0635) 2021; 206 Lizakowski (10.1016/j.eururo.2023.03.029_b0555) 2018; 50 Tang (10.1016/j.eururo.2023.03.029_b0570) 2018; 7 Brown (10.1016/j.eururo.2023.03.029_b0160) 2018; 118 Ihira (10.1016/j.eururo.2023.03.029_b0330) 2019; 120 Santucci (10.1016/j.eururo.2023.03.029_b0605) 2021; 148 Hadkhale (10.1016/j.eururo.2023.03.029_b0165) 2019; 58 Sathianathen (10.1016/j.eururo.2023.03.029_b0630) 2018; 36 10.1016/j.eururo.2023.03.029_b0175 Fang (10.1016/j.eururo.2023.03.029_b0450) 2018; 36 Zhao (10.1016/j.eururo.2023.03.029_b0125) 2022; 54 Cardwell (10.1016/j.eururo.2023.03.029_b0580) 2021; 116 Ramirez (10.1016/j.eururo.2023.03.029_b0020) 2016; 117 Acham (10.1016/j.eururo.2023.03.029_b0225) 2020; 74 Sung (10.1016/j.eururo.2023.03.029_b0070) 2021; 71 Cumberbatch (10.1016/j.eururo.2023.03.029_b0045) 2015; 1 Freedman (10.1016/j.eururo.2023.03.029_b0110) 2011; 306 |
| References_xml | – volume: 44 start-page: e2022050 year: 2022 ident: b0500 article-title: The relationship between metabolic syndrome and its components with bladder cancer: a systematic review and meta-analysis of cohort studies publication-title: Epidemiol Health – volume: 68 start-page: 394 year: 2018 end-page: 424 ident: b0005 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin – volume: 24 start-page: 957 year: 2019 end-page: 965 ident: b0460 article-title: Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer publication-title: Int J Clin Oncol – volume: 51 start-page: 692 year: 2021 end-page: 699 ident: b0535 article-title: The cancer risk according to three subtypes of ANCA-associated vasculitis: a propensity score-matched analysis of a nationwide study publication-title: Semin Arthritis Rheum – volume: 12 start-page: 3468 year: 2023 end-page: 3476 ident: b0150 article-title: Association between cannabis use with urological cancers: a population-based cohort study and a Mendelian randomization study in the UK Biobank publication-title: Cancer Med – volume: 37 start-page: 2393 year: 2019 end-page: 2400 ident: b0490 article-title: Association of body mass index with bladder cancer risk in men depends on abdominal obesity publication-title: World J Urol – volume: 38 start-page: 816 year: 2020 end-page: 825 ident: b0620 article-title: Androgen deprivation therapy for prostate cancer and the risk of bladder cancer: a systematic review of observational studies publication-title: Urol Oncol – volume: 146 start-page: 874 year: 2020 end-page: 883 ident: b0120 article-title: The future burden of kidney and bladder cancers preventable by behavior modification in Australia: a pooled cohort study publication-title: Int J Cancer – volume: 36 start-page: 781 year: 2021 end-page: 792 ident: b0230 article-title: The association between meat and fish consumption and bladder cancer risk: a pooled analysis of 11 cohort studies publication-title: Eur J Epidemiol – volume: 19 start-page: 495 year: 2022 end-page: 509 ident: b0385 article-title: Bladder cancer, inflammageing and microbiomes publication-title: Nat Rev Urol – volume: 37 start-page: 639 year: 2020 end-page: 654.e6 ident: b0310 article-title: Comprehensive analysis of genetic ancestry and its molecular correlates in cancer publication-title: Cancer Cell – volume: 53 start-page: 471 year: 2021 end-page: 477 ident: b0565 article-title: Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis publication-title: Int Urol Nephrol – volume: 148 start-page: 1372 year: 2021 end-page: 1382 ident: b0605 article-title: Aspirin and the risk of nondigestive tract cancers: an updated meta-analysis to 2019 publication-title: Int J Cancer – start-page: 19 year: 2021 ident: b0525 article-title: Atopy, asthma, and risk of bladder cancer: systematic review and meta-analysis of cohort studies publication-title: Eur J Inflamm – volume: 473 start-page: 174 year: 2011 end-page: 180 ident: b0420 article-title: Enterotypes of the human gut microbiome publication-title: Nature – volume: 116 start-page: 1612 year: 2021 end-page: 1619 ident: b0580 article-title: Exposure to ranitidine and risk of bladder cancer: a nested case-control study publication-title: Am J Gastroenterol – volume: 97 start-page: e11596 year: 2018 ident: b0600 article-title: Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: a systematic review and meta-analysis publication-title: Medicine (Baltimore) – volume: 149 start-page: 778 year: 2021 end-page: 789 ident: b0075 article-title: Cancer statistics for the year 2020: an overview publication-title: Int J Cancer – reference: Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer; 2020. – volume: 10 start-page: 1332 year: 2021 end-page: 1341 ident: b0545 article-title: Inflammatory bowel disease and risk of urinary cancers: a systematic review and pooled analysis of population-based studies publication-title: Transl Androl Urol – volume: 147 start-page: 2091 year: 2020 end-page: 2100 ident: b0235 article-title: Fruit consumption and the risk of bladder cancer: a pooled analysis by the Bladder Cancer Epidemiology and Nutritional Determinants study publication-title: Int J Cancer – volume: 63 start-page: 234 year: 2013 end-page: 241 ident: b0050 article-title: Epidemiology and risk factors of urothelial bladder cancer publication-title: Eur Urol – volume: 719 year: 2019 ident: b0355 article-title: Glutathione S-transferase Pi 1 (GSTP1) Gene 313 A/G (rs1695) polymorphism is associated with the risk of urinary bladder cancer: evidence from a systematic review and meta-analysis based on 34 case-control studies publication-title: Gene – volume: 142 start-page: 486 year: 2020 end-page: 492 ident: b0520 article-title: Types of occult cancer in stroke and the relation to smoking publication-title: Acta Neurol Scand – volume: 66 year: 2020 ident: b0585 article-title: Levothyroxine treatment is associated with an increased relative risk of overall and organ specific incident cancers—a cohort study of the Swedish population publication-title: Cancer Epidemiol – volume: 202 start-page: 484 year: 2019 end-page: 489 ident: b0245 article-title: Association between inflammatory potential of diet and bladder cancer risk: results of 3 United States prospective cohort studies publication-title: J Urol – reference: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some drinking-water disinfectants and contaminants, including arsenic. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 84. International Agency for Research on Cancer; 2004. – volume: 126 start-page: 1499 year: 2022 end-page: 1507 ident: b0280 article-title: Long-term exposure to ambient air pollution and bladder cancer incidence in a pooled European cohort: the ELAPSE project publication-title: Br J Cancer – volume: 4 start-page: 766 year: 2021 end-page: 783 ident: b0145 article-title: Carcinogen biomarkers in the urine of electronic cigarette users and implications for the development of bladder cancer: a systematic review publication-title: Eur Urol Oncol – volume: 59 start-page: 287 year: 2020 end-page: 296 ident: b0180 article-title: An inverse association between the Mediterranean diet and bladder cancer risk: a pooled analysis of 13 cohort studies publication-title: Eur J Nutr – volume: 119 year: 2022 ident: b0405 article-title: limits bladder uropathogenic publication-title: Proc Natl Acad Sci U S A – volume: 124 start-page: 1006 year: 2019 end-page: 1013 ident: b0475 article-title: Long-term incidence of secondary bladder and rectal cancer in patients treated with brachytherapy for localized prostate cancer: a large-scale population-based analysis publication-title: BJU Int – volume: 10 start-page: 164 year: 2021 end-page: 173 ident: b0550 article-title: Does inflammatory bowel disease increase the risk of lower urinary tract tumors: a meta-analysis publication-title: Transl Androl Urol – volume: 20 start-page: 568 year: 2022 end-page: 574 ident: b0095 article-title: Incidence of germline variants in familial bladder cancer and among patients with cancer predisposition syndromes publication-title: Clin Genitourin Cancer – volume: 135 year: 2020 ident: b0275 article-title: Diesel exhaust and bladder cancer risk by pathologic stage and grade subtypes publication-title: Environ Int – volume: 78 start-page: 893 year: 2020 end-page: 906 ident: b0315 article-title: Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita publication-title: Eur Urol – volume: 37 start-page: 1386 year: 2018 end-page: 1395 ident: b0435 article-title: Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: A systematic review publication-title: Neurourol Urodyn – volume: 168 start-page: 2236 year: 2002 end-page: 2239 ident: b0400 article-title: species is more cytotoxic to human bladder cancer cells than publication-title: J Urol – volume: 14 start-page: e0222875 year: 2019 ident: b0455 article-title: A population-based cohort study examining the association of documented bladder diverticulum and bladder cancer risk in urology patients publication-title: PLoS One – reference: International Agency for Research on Cancer. List of classifications by cancer sites with sufficient or limited evidence in humans. IARC monographs volumes 1–132. July 1, 2022. – volume: 11 start-page: e050728 year: 2021 ident: b0440 article-title: Association between chronic bladder catheterisation and bladder cancer incidence and mortality: a population-based retrospective cohort study in Ontario, Canada publication-title: BMJ Open – volume: 400 start-page: 1712 year: 2022 end-page: 1721 ident: b0025 article-title: Current best practice for bladder cancer: a narrative review of diagnostics and treatments publication-title: Lancet – volume: 28 start-page: 2333 year: 2022 end-page: 2343 ident: b0345 article-title: Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome publication-title: Nat Med – volume: 372 year: 2021 ident: b0060 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: BMJ – volume: 74 start-page: 28 year: 2020 end-page: 35 ident: b0225 article-title: Intake of milk and other dairy products and the risk of bladder cancer: a pooled analysis of 13 cohort studies publication-title: Eur J Clin Nutr – volume: 12 start-page: 305 year: 2019 end-page: 314 ident: b0130 article-title: Smoking cessation and the risk of bladder cancer among postmenopausal women publication-title: Cancer Prev Res – volume: 177 start-page: 27 year: 2020 end-page: 40 ident: b0360 article-title: Effects of arsenic (+3 oxidation state) methyltransferase gene polymorphisms and expression on bladder cancer: evidence from a systematic review, meta-analysis and TCGA dataset publication-title: Toxicol Sci – volume: 22 start-page: 471 year: 2022 end-page: 480 ident: b0485 article-title: Risk and prognosis of secondary bladder cancer after post-operative radiotherapy for gynecological cancer publication-title: Bosn J Basic Med Sci – reference: Bukavina L, Isali I, Ginwala R, et al. Global meta-analysis of urine microbiome: colonization of PAH-degrading bacteria among bladder cancer patients. Eur Urol Oncol. In press. – volume: 117 start-page: 783 year: 2016 end-page: 786 ident: b0020 article-title: Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer publication-title: BJU Int – volume: 7 start-page: 1070 year: 2018 end-page: 1080 ident: b0570 article-title: Pioglitazone and bladder cancer risk: a systematic review and meta-analysis publication-title: Cancer Med – volume: 56 start-page: 441 year: 2020 ident: b0505 article-title: Incidence of bladder cancer in type 2 diabetes mellitus patients: a population-based cohort study publication-title: Medicina (Kaunas) – volume: 12 start-page: 1545 year: 2020 end-page: 1562 ident: b0590 article-title: Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis publication-title: Aging (Albany NY) – volume: 35 start-page: 641 year: 2020 end-page: 651 ident: b0515 article-title: Site-specific cancer risk in patients with type 2 diabetes: a nationwide population-based cohort study in Korea publication-title: Korean J Intern Med – volume: 46 start-page: 573 year: 2018 end-page: 579 ident: b0445 article-title: The risk of bladder cancer in patients with urinary calculi: a meta-analysis publication-title: Urolithiasis – volume: 385 start-page: 966 year: 2015 end-page: 976 ident: b0030 article-title: Global trends and projections for tobacco use, 1990–2025: an analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control publication-title: Lancet – volume: 75 start-page: 637 year: 2019 end-page: 646 ident: b0375 article-title: The microbiome and genitourinary cancer: a collaborative review publication-title: Eur Urol – volume: 54 start-page: 1169 year: 2022 end-page: 1185 ident: b0125 article-title: Cigarette smoking and risk of bladder cancer: a dose-response meta-analysis publication-title: Int Urol Nephrol – volume: 36 start-page: 338.e13 year: 2018 end-page: 338.e17 ident: b0630 article-title: Finasteride does not prevent bladder cancer: a secondary analysis of the Medical Therapy for Prostatic Symptoms Study publication-title: Urol Oncol – volume: 8 start-page: e649 year: 2020 end-page: e660 ident: b0155 article-title: Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study publication-title: Lancet Glob Health – volume: 29 start-page: 395 year: 2020 end-page: 403 ident: b0410 article-title: Gut microbial composition changes in bladder cancer patients: a case-control study in Harbin, China publication-title: Asia Pac J Clin Nutr – reference: Bukavina L, Calaway A, Isali I, et al. Characterization and functional analysis of microbiome in bladder cancer. Presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium; February 17–19, 2022; San Francisco, CA, USA. – volume: 88 start-page: 1083 year: 2008 end-page: 1087 ident: b0220 article-title: Cultured milk, yogurt, and dairy intake in relation to bladder cancer risk in a prospective study of Swedish women and men publication-title: Am J Clin Nutr – volume: 6 year: 2021 ident: b0085 article-title: Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease study 2019 publication-title: BMJ Glob Health – volume: 145 start-page: 894 year: 2019 end-page: 900 ident: b0285 article-title: Ambient air pollution and incident bladder cancer risk: updated analysis of the Spanish Bladder Cancer Study publication-title: Int J Cancer – volume: 23 start-page: 971 year: 2020 end-page: 978 ident: b0625 article-title: Clinical significance of 5-alpha reductase inhibitor and androgen deprivation therapy in bladder cancer incidence, recurrence, and survival: a meta-analysis and systemic review publication-title: Aging Male – volume: 45 year: 2021 ident: b0560 article-title: Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients publication-title: Clin Res Hepatol Gastroenterol – volume: 36 start-page: 1181 year: 2018 end-page: 1190 ident: b0425 article-title: Role of urinary tract infection in bladder cancer: a systematic review and meta-analysis publication-title: World J Urol – volume: 8 start-page: 167 year: 2018 ident: b0365 article-title: Profiling the urinary microbiota in male patients with bladder cancer in China publication-title: Front Cell Infect Microbiol – volume: 120 start-page: 571 year: 2019 end-page: 574 ident: b0330 article-title: Physical activity and subsequent risk of kidney, bladder and upper urinary tract cancer in the Japanese population: the Japan Public Health Centre-based Prospective Study publication-title: Br J Cancer – volume: 37 start-page: 2313 year: 2019 end-page: 2324 ident: b0200 article-title: Impact of alcohol consumption on the risk of developing bladder cancer: a systematic review and meta-analysis publication-title: World J Urol – volume: 38 start-page: 2827 year: 2020 end-page: 2834 ident: b0430 article-title: Traumatic spinal cord injury confers bladder cancer risk to patients managed without permanent urinary catheterization: lessons from a comparison of clinical data with the national database publication-title: World J Urol – volume: 8 start-page: 12157 year: 2018 ident: b0370 article-title: The urinary microbiome associated with bladder cancer publication-title: Sci Rep – volume: 35 start-page: 523 year: 2020 end-page: 535 ident: b0210 article-title: Coffee consumption and risk of bladder cancer: a pooled analysis of 501,604 participants from 12 cohort studies in the BLadder Cancer Epidemiology and Nutritional Determinants (BLEND) international study publication-title: Eur J Epidemiol – volume: 31 start-page: 503 year: 2020 end-page: 510 ident: b0510 article-title: The association between type 2 diabetes mellitus and bladder cancer risk among postmenopausal women publication-title: Cancer Causes Control – volume: 37 start-page: 460 year: 2022 end-page: 467 ident: b0540 article-title: Cancer risk in Korean patients with gout publication-title: Korean J Intern Med – volume: 50 start-page: 1881 year: 2018 end-page: 1888 ident: b0555 article-title: Solid organ cancer and melanoma in kidney transplant recipients: TumorTx base preliminary results publication-title: Transplant Proc – volume: 28 start-page: 76 year: 2019 end-page: 80 ident: b0615 article-title: Bladder cancer risk in users of selected drugs for cardiovascular disease prevention publication-title: Eur J Cancer Prev – volume: 71 start-page: 209 year: 2021 end-page: 249 ident: b0070 article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin – volume: 203 start-page: 123 year: 2022 end-page: 129 ident: b0290 article-title: Chronic exposure to nitrate in drinking water and the risk of bladder cancer: a meta-analysis of epidemiological evidence publication-title: Public Health – volume: 11 start-page: 587 year: 2019 end-page: 598 ident: b0470 article-title: High prevalence of secondary bladder cancer in men on radiotherapy for prostate cancer: evidence from a meta-analysis publication-title: Cancer Manag Res – volume: 79 start-page: 82 year: 2021 end-page: 104 ident: b0015 article-title: European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines publication-title: Eur Urol – volume: 147 start-page: 2717 year: 2020 end-page: 2724 ident: b0325 article-title: Physical activity and risk of bladder cancer among postmenopausal women publication-title: Int J Cancer – volume: 39 start-page: 202 year: 2021 end-page: 214 ident: b0010 article-title: Radical cystectomy against intravesical BCG for high-risk high-grade nonmuscle invasive bladder cancer: results from the randomized controlled BRAVO-feasibility study publication-title: J Clin Oncol – volume: 112 start-page: 1252 year: 2020 end-page: 1266 ident: b0190 article-title: Grain and dietary fiber intake and bladder cancer risk: a pooled analysis of prospective cohort studies publication-title: Am J Clin Nutr – volume: 206 start-page: 15 year: 2021 end-page: 21 ident: b0635 article-title: Finasteride use and risk of bladder cancer in a multiethnic population publication-title: J Urol – volume: 124 start-page: 513 year: 2021 end-page: 523 ident: b0195 article-title: Alcohol consumption, drinking patterns and cancer incidence in an Australian cohort of 226,162 participants aged 45 years and over publication-title: Br J Cancer – volume: 19 start-page: 56 year: 2021 ident: b0240 article-title: Vegetable intake and the risk of bladder cancer in the BLadder Cancer Epidemiology and Nutritional Determinants (BLEND) international study publication-title: BMC Med – volume: 143 start-page: 3071 year: 2018 end-page: 3082 ident: b0495 article-title: Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: a prospective pooled cohort study of 800,000 men and women publication-title: Int J Cancer – volume: 370 year: 2020 ident: b0300 article-title: Personal use of permanent hair dyes and cancer risk and mortality in US women: prospective cohort study publication-title: BMJ – volume: 21 start-page: 1871 year: 2019 end-page: 1877 ident: b0595 article-title: Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: a meta-analysis of randomized controlled trials publication-title: Diabetes Obes Metab – volume: 23 start-page: 614 year: 2020 end-page: 620 ident: b0530 article-title: An updated meta-analysis on the risk of urologic cancer in patients with systemic lupus erythematosus publication-title: Arch Iran Med – volume: 319 start-page: 2039 year: 2018 end-page: 2041 ident: b0040 article-title: Changes in electronic cigarette use among adults in the United States, 2014–2016 publication-title: JAMA – volume: 74 start-page: 784 year: 2018 end-page: 795 ident: b0055 article-title: Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018 publication-title: Eur Urol – volume: 188 start-page: 134 year: 2019 end-page: 140 ident: b0250 article-title: Low serum 25-hydroxyvitamin D is associated with increased bladder cancer risk: a systematic review and evidence of a potential mechanism publication-title: J Steroid Biochem Mol Biol – reference: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Outdoor air pollution. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 109. International Agency for Research on Cancer; 2015. – volume: 10 year: 2020 ident: b0390 article-title: Alterations in urobiome in patients with bladder cancer and implications for clinical outcome: a single-institution study publication-title: Front Cell Infect Microbiol – volume: 1 start-page: 3 year: 2015 end-page: 16 ident: b0035 article-title: Global and regional patterns of tobacco smoking and tobacco control policies publication-title: Eur Urol Focus – volume: 118 start-page: 1130 year: 2018 end-page: 1141 ident: b0160 article-title: The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015 publication-title: Br J Cancer – volume: 126 start-page: 1765 year: 2022 end-page: 1773 ident: b0305 article-title: Differences in cancer incidence by broad ethnic group in England, 2013–2017 publication-title: Br J Cancer – reference: Sweis R, Golan S, Barashi N, et al. Association of the commensal urinary microbiome with response to bacillus Calmette-Guérin (BCG) immunotherapy in nonmuscle invasive bladder cancer. Presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium; February 14–16, 2019; San Francisco, CA, USA. – volume: 70 start-page: 1217 year: 2018 end-page: 1227 ident: b0205 article-title: The effect of daily fluid management and beverages consumption on the risk of bladder cancer: a meta-analysis of observational study publication-title: Nutr Cancer – volume: 1 start-page: 1282 year: 2015 end-page: 1290 ident: b0045 article-title: Contemporary occupational carcinogen exposure and bladder cancer: a systematic review and meta-analysis publication-title: JAMA Oncol – reference: Roser M, Ritchie H. Cancer. Our world in data. July 2015. – volume: 306 start-page: 737 year: 2011 end-page: 745 ident: b0110 article-title: Association between smoking and risk of bladder cancer among men and women publication-title: JAMA – volume: 81 start-page: 466 year: 2022 end-page: 473 ident: b0480 article-title: Genomic features of muscle-invasive bladder cancer arising after prostate radiotherapy publication-title: Eur Urol – volume: 75 start-page: 319 year: 2019 end-page: 328 ident: b0465 article-title: External beam radiotherapy increases the risk of bladder cancer when compared with radical prostatectomy in patients affected by prostate cancer: a population-based analysis publication-title: Eur Urol – volume: 58 start-page: 29 year: 2019 end-page: 37 ident: b0165 article-title: Occupational variation in bladder cancer in Nordic males adjusted with approximated smoking prevalence publication-title: Acta Oncol – volume: 41 start-page: 1122 year: 2022 end-page: 1130 ident: b0215 article-title: Tea consumption and risk of bladder cancer in the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) study: pooled analysis of 12 international cohort studies publication-title: Clin Nutr – volume: 214 year: 2022 ident: b0295 article-title: Chlorination by-products in drinking water and risk of bladder cancer—a population-based cohort study publication-title: Water Res – volume: 8 start-page: 507 year: 2018 ident: b0140 article-title: Comparison of bladder carcinogens in the urine of e-cigarette users versus non e-cigarette using controls publication-title: Sci Rep – reference: World Cancer Research Fund/American Institute for Cancer Research. Diet, nutrition, physical activity and bladder cancer. Continuous update project expert report. 2015. – volume: 61 start-page: 2397 year: 2022 end-page: 2416 ident: b0255 article-title: Dietary B group vitamin intake and the bladder cancer risk: a pooled analysis of prospective cohort studies publication-title: Eur J Nutr – volume: 110 start-page: 722 year: 2019 end-page: 731 ident: b0320 article-title: Trends in socio-economic inequalities in bladder cancer incidence in Canada: 1992–2010 publication-title: Can J Public Health – volume: 147 start-page: 3394 year: 2020 end-page: 3403 ident: b0185 article-title: Adherence to a Western dietary pattern and risk of bladder cancer: a pooled analysis of 13 cohort studies of the Bladder Cancer Epidemiology and Nutritional Determinants international study publication-title: Int J Cancer – volume: 145 start-page: 2639 year: 2019 end-page: 2646 ident: b0170 article-title: Cancer incidence and mortality among firefighters publication-title: Int J Cancer – volume: 36 start-page: 931 year: 2018 end-page: 938 ident: b0450 article-title: Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study publication-title: World J Urol – volume: 6 start-page: 61 year: 2018 end-page: 68 ident: b0575 article-title: Pioglitazone and risk of bladder cancer in type 2 diabetes mellitus patients: A systematic literature review and meta-analysis of observational studies using real-world data publication-title: Clin Epidemiol Global Health – reference: . – volume: 17 year: 2019 ident: b0265 article-title: Low-level exposure to arsenic in drinking water and risk of lung and bladder cancer: a systematic review and dose-response meta-analysis publication-title: Dose Response – volume: 18 start-page: 1088 year: 2018 ident: b0350 article-title: Association of Glutathione S-transferase gene polymorphism with bladder cancer susceptibility publication-title: BMC Cancer – volume: 13 start-page: 3927 year: 2021 ident: b0335 article-title: Association between coffee consumption/physical exercise and gastric, hepatic, colon, breast, uterine cervix, lung, thyroid, prostate, and bladder cancer publication-title: Nutrients – volume: 11 start-page: 6195 year: 2020 ident: b0100 article-title: Common germline-somatic variant interactions in advanced urothelial cancer publication-title: Nat Commun – volume: 757 year: 2020 ident: b0340 article-title: N-acetyltransferase 2 polymorphism is associated with bladder cancer risk: an updated meta-analysis based on 54 case-control studies publication-title: Gene – volume: 10 start-page: 3781 year: 2018 end-page: 3791 ident: b0135 article-title: Secondhand smoking increases bladder cancer risk in nonsmoking population: a meta-analysis publication-title: Cancer Manag Res – volume: 145 start-page: 267 year: 2019 end-page: 273 ident: b0610 article-title: Long-term use of low-dose aspirin for cancer prevention: a 10-year population cohort study in Hong Kong publication-title: Int J Cancer – reference: Ferlay J, Laversanne M, Ervik M, et al. Global cancer observatory: cancer tomorrow. Lyon, France: International Agency for Research on Cancer; 2020. – volume: 9 start-page: 17420 year: 2018 end-page: 17429 ident: b0115 article-title: Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: a retrospective study of 422,010 patients followed for up to 30 years publication-title: Oncotarget – start-page: 19 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0525 article-title: Atopy, asthma, and risk of bladder cancer: systematic review and meta-analysis of cohort studies publication-title: Eur J Inflamm – volume: 147 start-page: 2717 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0325 article-title: Physical activity and risk of bladder cancer among postmenopausal women publication-title: Int J Cancer doi: 10.1002/ijc.33042 – volume: 36 start-page: 931 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0450 article-title: Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study publication-title: World J Urol doi: 10.1007/s00345-018-2216-8 – volume: 10 start-page: 164 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0550 article-title: Does inflammatory bowel disease increase the risk of lower urinary tract tumors: a meta-analysis publication-title: Transl Androl Urol doi: 10.21037/tau-20-1020 – ident: 10.1016/j.eururo.2023.03.029_b0380 doi: 10.1016/j.euo.2023.02.004 – volume: 4 start-page: 766 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0145 article-title: Carcinogen biomarkers in the urine of electronic cigarette users and implications for the development of bladder cancer: a systematic review publication-title: Eur Urol Oncol doi: 10.1016/j.euo.2020.02.004 – volume: 13 start-page: 3927 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0335 article-title: Association between coffee consumption/physical exercise and gastric, hepatic, colon, breast, uterine cervix, lung, thyroid, prostate, and bladder cancer publication-title: Nutrients doi: 10.3390/nu13113927 – volume: 12 start-page: 3468 year: 2023 ident: 10.1016/j.eururo.2023.03.029_b0150 article-title: Association between cannabis use with urological cancers: a population-based cohort study and a Mendelian randomization study in the UK Biobank publication-title: Cancer Med doi: 10.1002/cam4.5132 – volume: 88 start-page: 1083 year: 2008 ident: 10.1016/j.eururo.2023.03.029_b0220 article-title: Cultured milk, yogurt, and dairy intake in relation to bladder cancer risk in a prospective study of Swedish women and men publication-title: Am J Clin Nutr doi: 10.1093/ajcn/88.4.1083 – volume: 19 start-page: 56 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0240 article-title: Vegetable intake and the risk of bladder cancer in the BLadder Cancer Epidemiology and Nutritional Determinants (BLEND) international study publication-title: BMC Med doi: 10.1186/s12916-021-01931-8 – volume: 35 start-page: 641 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0515 article-title: Site-specific cancer risk in patients with type 2 diabetes: a nationwide population-based cohort study in Korea publication-title: Korean J Intern Med doi: 10.3904/kjim.2017.402 – volume: 9 start-page: 17420 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0115 article-title: Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: a retrospective study of 422,010 patients followed for up to 30 years publication-title: Oncotarget doi: 10.18632/oncotarget.24724 – volume: 36 start-page: 1181 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0425 article-title: Role of urinary tract infection in bladder cancer: a systematic review and meta-analysis publication-title: World J Urol doi: 10.1007/s00345-018-2257-z – volume: 29 start-page: 395 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0410 article-title: Gut microbial composition changes in bladder cancer patients: a case-control study in Harbin, China publication-title: Asia Pac J Clin Nutr – volume: 37 start-page: 2313 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0200 article-title: Impact of alcohol consumption on the risk of developing bladder cancer: a systematic review and meta-analysis publication-title: World J Urol doi: 10.1007/s00345-019-02825-4 – ident: 10.1016/j.eururo.2023.03.029_b0090 – volume: 74 start-page: 28 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0225 article-title: Intake of milk and other dairy products and the risk of bladder cancer: a pooled analysis of 13 cohort studies publication-title: Eur J Clin Nutr doi: 10.1038/s41430-019-0453-6 – volume: 306 start-page: 737 year: 2011 ident: 10.1016/j.eururo.2023.03.029_b0110 article-title: Association between smoking and risk of bladder cancer among men and women publication-title: JAMA doi: 10.1001/jama.2011.1142 – volume: 214 year: 2022 ident: 10.1016/j.eururo.2023.03.029_b0295 article-title: Chlorination by-products in drinking water and risk of bladder cancer—a population-based cohort study publication-title: Water Res doi: 10.1016/j.watres.2022.118202 – volume: 12 start-page: 305 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0130 article-title: Smoking cessation and the risk of bladder cancer among postmenopausal women publication-title: Cancer Prev Res doi: 10.1158/1940-6207.CAPR-18-0441 – volume: 719 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0355 article-title: Glutathione S-transferase Pi 1 (GSTP1) Gene 313 A/G (rs1695) polymorphism is associated with the risk of urinary bladder cancer: evidence from a systematic review and meta-analysis based on 34 case-control studies publication-title: Gene doi: 10.1016/j.gene.2019.144077 – volume: 8 start-page: e649 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0155 article-title: Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(20)30059-0 – volume: 146 start-page: 874 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0120 article-title: The future burden of kidney and bladder cancers preventable by behavior modification in Australia: a pooled cohort study publication-title: Int J Cancer doi: 10.1002/ijc.32420 – ident: 10.1016/j.eururo.2023.03.029_b0395 doi: 10.1200/JCO.2019.37.7_suppl.423 – volume: 149 start-page: 778 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0075 article-title: Cancer statistics for the year 2020: an overview publication-title: Int J Cancer doi: 10.1002/ijc.33588 – volume: 14 start-page: e0222875 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0455 article-title: A population-based cohort study examining the association of documented bladder diverticulum and bladder cancer risk in urology patients publication-title: PLoS One doi: 10.1371/journal.pone.0222875 – volume: 126 start-page: 1499 year: 2022 ident: 10.1016/j.eururo.2023.03.029_b0280 article-title: Long-term exposure to ambient air pollution and bladder cancer incidence in a pooled European cohort: the ELAPSE project publication-title: Br J Cancer doi: 10.1038/s41416-022-01735-4 – volume: 36 start-page: 781 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0230 article-title: The association between meat and fish consumption and bladder cancer risk: a pooled analysis of 11 cohort studies publication-title: Eur J Epidemiol doi: 10.1007/s10654-021-00762-4 – volume: 119 year: 2022 ident: 10.1016/j.eururo.2023.03.029_b0405 article-title: Lactobacillus crispatus limits bladder uropathogenic E. coli infection by triggering a host type I interferon response publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.2117904119 – volume: 31 start-page: 503 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0510 article-title: The association between type 2 diabetes mellitus and bladder cancer risk among postmenopausal women publication-title: Cancer Causes Control – volume: 757 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0340 article-title: N-acetyltransferase 2 polymorphism is associated with bladder cancer risk: an updated meta-analysis based on 54 case-control studies publication-title: Gene doi: 10.1016/j.gene.2020.144924 – volume: 53 start-page: 471 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0565 article-title: Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis publication-title: Int Urol Nephrol doi: 10.1007/s11255-020-02659-9 – volume: 28 start-page: 76 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0615 article-title: Bladder cancer risk in users of selected drugs for cardiovascular disease prevention publication-title: Eur J Cancer Prev doi: 10.1097/CEJ.0000000000000419 – volume: 8 start-page: 167 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0365 article-title: Profiling the urinary microbiota in male patients with bladder cancer in China publication-title: Front Cell Infect Microbiol doi: 10.3389/fcimb.2018.00167 – volume: 118 start-page: 1130 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0160 article-title: The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015 publication-title: Br J Cancer doi: 10.1038/s41416-018-0029-6 – volume: 147 start-page: 2091 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0235 article-title: Fruit consumption and the risk of bladder cancer: a pooled analysis by the Bladder Cancer Epidemiology and Nutritional Determinants study publication-title: Int J Cancer doi: 10.1002/ijc.33008 – volume: 97 start-page: e11596 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0600 article-title: Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: a systematic review and meta-analysis publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000011596 – volume: 36 start-page: 338.e13 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0630 article-title: Finasteride does not prevent bladder cancer: a secondary analysis of the Medical Therapy for Prostatic Symptoms Study publication-title: Urol Oncol doi: 10.1016/j.urolonc.2018.03.020 – volume: 319 start-page: 2039 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0040 article-title: Changes in electronic cigarette use among adults in the United States, 2014–2016 publication-title: JAMA doi: 10.1001/jama.2018.4658 – volume: 1 start-page: 1282 year: 2015 ident: 10.1016/j.eururo.2023.03.029_b0045 article-title: Contemporary occupational carcinogen exposure and bladder cancer: a systematic review and meta-analysis publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2015.3209 – volume: 124 start-page: 513 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0195 article-title: Alcohol consumption, drinking patterns and cancer incidence in an Australian cohort of 226,162 participants aged 45 years and over publication-title: Br J Cancer doi: 10.1038/s41416-020-01101-2 – volume: 206 start-page: 15 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0635 article-title: Finasteride use and risk of bladder cancer in a multiethnic population publication-title: J Urol doi: 10.1097/JU.0000000000001694 – volume: 147 start-page: 3394 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0185 article-title: Adherence to a Western dietary pattern and risk of bladder cancer: a pooled analysis of 13 cohort studies of the Bladder Cancer Epidemiology and Nutritional Determinants international study publication-title: Int J Cancer doi: 10.1002/ijc.33173 – volume: 370 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0300 article-title: Personal use of permanent hair dyes and cancer risk and mortality in US women: prospective cohort study publication-title: BMJ – volume: 10 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0390 article-title: Alterations in urobiome in patients with bladder cancer and implications for clinical outcome: a single-institution study publication-title: Front Cell Infect Microbiol doi: 10.3389/fcimb.2020.555508 – volume: 8 start-page: 12157 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0370 article-title: The urinary microbiome associated with bladder cancer publication-title: Sci Rep doi: 10.1038/s41598-018-29054-w – volume: 142 start-page: 486 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0520 article-title: Types of occult cancer in stroke and the relation to smoking publication-title: Acta Neurol Scand doi: 10.1111/ane.13299 – volume: 35 start-page: 523 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0210 article-title: Coffee consumption and risk of bladder cancer: a pooled analysis of 501,604 participants from 12 cohort studies in the BLadder Cancer Epidemiology and Nutritional Determinants (BLEND) international study publication-title: Eur J Epidemiol doi: 10.1007/s10654-019-00597-0 – volume: 37 start-page: 460 year: 2022 ident: 10.1016/j.eururo.2023.03.029_b0540 article-title: Cancer risk in Korean patients with gout publication-title: Korean J Intern Med doi: 10.3904/kjim.2020.259 – volume: 75 start-page: 319 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0465 article-title: External beam radiotherapy increases the risk of bladder cancer when compared with radical prostatectomy in patients affected by prostate cancer: a population-based analysis publication-title: Eur Urol doi: 10.1016/j.eururo.2018.09.034 – volume: 20 start-page: 568 year: 2022 ident: 10.1016/j.eururo.2023.03.029_b0095 article-title: Incidence of germline variants in familial bladder cancer and among patients with cancer predisposition syndromes publication-title: Clin Genitourin Cancer doi: 10.1016/j.clgc.2022.08.009 – volume: 385 start-page: 966 year: 2015 ident: 10.1016/j.eururo.2023.03.029_b0030 article-title: Global trends and projections for tobacco use, 1990–2025: an analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control publication-title: Lancet doi: 10.1016/S0140-6736(15)60264-1 – volume: 56 start-page: 441 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0505 article-title: Incidence of bladder cancer in type 2 diabetes mellitus patients: a population-based cohort study publication-title: Medicina (Kaunas) doi: 10.3390/medicina56090441 – volume: 39 start-page: 202 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0010 article-title: Radical cystectomy against intravesical BCG for high-risk high-grade nonmuscle invasive bladder cancer: results from the randomized controlled BRAVO-feasibility study publication-title: J Clin Oncol doi: 10.1200/JCO.20.01665 – volume: 38 start-page: 2827 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0430 article-title: Traumatic spinal cord injury confers bladder cancer risk to patients managed without permanent urinary catheterization: lessons from a comparison of clinical data with the national database publication-title: World J Urol doi: 10.1007/s00345-020-03077-3 – volume: 12 start-page: 1545 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0590 article-title: Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis publication-title: Aging (Albany NY) doi: 10.18632/aging.102699 – ident: 10.1016/j.eururo.2023.03.029_b0175 – ident: 10.1016/j.eururo.2023.03.029_b0065 – volume: 400 start-page: 1712 year: 2022 ident: 10.1016/j.eururo.2023.03.029_b0025 article-title: Current best practice for bladder cancer: a narrative review of diagnostics and treatments publication-title: Lancet doi: 10.1016/S0140-6736(22)01188-6 – volume: 126 start-page: 1765 year: 2022 ident: 10.1016/j.eururo.2023.03.029_b0305 article-title: Differences in cancer incidence by broad ethnic group in England, 2013–2017 publication-title: Br J Cancer doi: 10.1038/s41416-022-01718-5 – volume: 117 start-page: 783 year: 2016 ident: 10.1016/j.eururo.2023.03.029_b0020 article-title: Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer publication-title: BJU Int doi: 10.1111/bju.13345 – ident: 10.1016/j.eururo.2023.03.029_b0105 – volume: 37 start-page: 2393 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0490 article-title: Association of body mass index with bladder cancer risk in men depends on abdominal obesity publication-title: World J Urol doi: 10.1007/s00345-019-02690-1 – volume: 63 start-page: 234 year: 2013 ident: 10.1016/j.eururo.2023.03.029_b0050 article-title: Epidemiology and risk factors of urothelial bladder cancer publication-title: Eur Urol doi: 10.1016/j.eururo.2012.07.033 – volume: 124 start-page: 1006 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0475 article-title: Long-term incidence of secondary bladder and rectal cancer in patients treated with brachytherapy for localized prostate cancer: a large-scale population-based analysis publication-title: BJU Int doi: 10.1111/bju.14841 – volume: 372 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0060 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: BMJ – volume: 18 start-page: 1088 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0350 article-title: Association of Glutathione S-transferase gene polymorphism with bladder cancer susceptibility publication-title: BMC Cancer doi: 10.1186/s12885-018-5014-1 – volume: 19 start-page: 495 year: 2022 ident: 10.1016/j.eururo.2023.03.029_b0385 article-title: Bladder cancer, inflammageing and microbiomes publication-title: Nat Rev Urol doi: 10.1038/s41585-022-00611-3 – volume: 145 start-page: 267 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0610 article-title: Long-term use of low-dose aspirin for cancer prevention: a 10-year population cohort study in Hong Kong publication-title: Int J Cancer doi: 10.1002/ijc.32083 – volume: 68 start-page: 394 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0005 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin – volume: 10 start-page: 3781 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0135 article-title: Secondhand smoking increases bladder cancer risk in nonsmoking population: a meta-analysis publication-title: Cancer Manag Res doi: 10.2147/CMAR.S175062 – volume: 41 start-page: 1122 year: 2022 ident: 10.1016/j.eururo.2023.03.029_b0215 article-title: Tea consumption and risk of bladder cancer in the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) study: pooled analysis of 12 international cohort studies publication-title: Clin Nutr doi: 10.1016/j.clnu.2022.03.020 – volume: 112 start-page: 1252 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0190 article-title: Grain and dietary fiber intake and bladder cancer risk: a pooled analysis of prospective cohort studies publication-title: Am J Clin Nutr doi: 10.1093/ajcn/nqaa215 – volume: 203 start-page: 123 year: 2022 ident: 10.1016/j.eururo.2023.03.029_b0290 article-title: Chronic exposure to nitrate in drinking water and the risk of bladder cancer: a meta-analysis of epidemiological evidence publication-title: Public Health doi: 10.1016/j.puhe.2021.11.019 – volume: 51 start-page: 692 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0535 article-title: The cancer risk according to three subtypes of ANCA-associated vasculitis: a propensity score-matched analysis of a nationwide study publication-title: Semin Arthritis Rheum doi: 10.1016/j.semarthrit.2021.03.014 – volume: 22 start-page: 471 year: 2022 ident: 10.1016/j.eururo.2023.03.029_b0485 article-title: Risk and prognosis of secondary bladder cancer after post-operative radiotherapy for gynecological cancer publication-title: Bosn J Basic Med Sci – volume: 24 start-page: 957 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0460 article-title: Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer publication-title: Int J Clin Oncol doi: 10.1007/s10147-019-01427-9 – volume: 11 start-page: e050728 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0440 article-title: Association between chronic bladder catheterisation and bladder cancer incidence and mortality: a population-based retrospective cohort study in Ontario, Canada publication-title: BMJ Open doi: 10.1136/bmjopen-2021-050728 – volume: 116 start-page: 1612 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0580 article-title: Exposure to ranitidine and risk of bladder cancer: a nested case-control study publication-title: Am J Gastroenterol doi: 10.14309/ajg.0000000000001310 – volume: 70 start-page: 1217 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0205 article-title: The effect of daily fluid management and beverages consumption on the risk of bladder cancer: a meta-analysis of observational study publication-title: Nutr Cancer doi: 10.1080/01635581.2018.1512636 – volume: 38 start-page: 816 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0620 article-title: Androgen deprivation therapy for prostate cancer and the risk of bladder cancer: a systematic review of observational studies publication-title: Urol Oncol doi: 10.1016/j.urolonc.2020.04.028 – volume: 7 start-page: 1070 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0570 article-title: Pioglitazone and bladder cancer risk: a systematic review and meta-analysis publication-title: Cancer Med doi: 10.1002/cam4.1354 – volume: 11 start-page: 587 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0470 article-title: High prevalence of secondary bladder cancer in men on radiotherapy for prostate cancer: evidence from a meta-analysis publication-title: Cancer Manag Res doi: 10.2147/CMAR.S185867 – volume: 21 start-page: 1871 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0595 article-title: Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: a meta-analysis of randomized controlled trials publication-title: Diabetes Obes Metab doi: 10.1111/dom.13745 – volume: 8 start-page: 507 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0140 article-title: Comparison of bladder carcinogens in the urine of e-cigarette users versus non e-cigarette using controls publication-title: Sci Rep doi: 10.1038/s41598-017-19030-1 – ident: 10.1016/j.eururo.2023.03.029_b0260 – volume: 188 start-page: 134 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0250 article-title: Low serum 25-hydroxyvitamin D is associated with increased bladder cancer risk: a systematic review and evidence of a potential mechanism publication-title: J Steroid Biochem Mol Biol doi: 10.1016/j.jsbmb.2019.01.002 – volume: 50 start-page: 1881 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0555 article-title: Solid organ cancer and melanoma in kidney transplant recipients: TumorTx base preliminary results publication-title: Transplant Proc doi: 10.1016/j.transproceed.2018.02.146 – volume: 66 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0585 article-title: Levothyroxine treatment is associated with an increased relative risk of overall and organ specific incident cancers—a cohort study of the Swedish population publication-title: Cancer Epidemiol doi: 10.1016/j.canep.2020.101707 – volume: 473 start-page: 174 year: 2011 ident: 10.1016/j.eururo.2023.03.029_b0420 article-title: Enterotypes of the human gut microbiome publication-title: Nature doi: 10.1038/nature09944 – volume: 148 start-page: 1372 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0605 article-title: Aspirin and the risk of nondigestive tract cancers: an updated meta-analysis to 2019 publication-title: Int J Cancer doi: 10.1002/ijc.33311 – volume: 58 start-page: 29 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0165 article-title: Occupational variation in bladder cancer in Nordic males adjusted with approximated smoking prevalence publication-title: Acta Oncol doi: 10.1080/0284186X.2018.1518591 – volume: 59 start-page: 287 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0180 article-title: An inverse association between the Mediterranean diet and bladder cancer risk: a pooled analysis of 13 cohort studies publication-title: Eur J Nutr doi: 10.1007/s00394-019-01907-8 – ident: 10.1016/j.eururo.2023.03.029_b0080 – volume: 177 start-page: 27 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0360 article-title: Effects of arsenic (+3 oxidation state) methyltransferase gene polymorphisms and expression on bladder cancer: evidence from a systematic review, meta-analysis and TCGA dataset publication-title: Toxicol Sci doi: 10.1093/toxsci/kfaa087 – volume: 10 start-page: 1332 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0545 article-title: Inflammatory bowel disease and risk of urinary cancers: a systematic review and pooled analysis of population-based studies publication-title: Transl Androl Urol doi: 10.21037/tau-20-1358 – volume: 17 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0265 article-title: Low-level exposure to arsenic in drinking water and risk of lung and bladder cancer: a systematic review and dose-response meta-analysis publication-title: Dose Response doi: 10.1177/1559325819863634 – volume: 168 start-page: 2236 year: 2002 ident: 10.1016/j.eururo.2023.03.029_b0400 article-title: Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium bovis (bacillus Calmette-Guerin) publication-title: J Urol doi: 10.1016/S0022-5347(05)64362-5 – volume: 11 start-page: 6195 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0100 article-title: Common germline-somatic variant interactions in advanced urothelial cancer publication-title: Nat Commun doi: 10.1038/s41467-020-19971-8 – volume: 145 start-page: 2639 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0170 article-title: Cancer incidence and mortality among firefighters publication-title: Int J Cancer doi: 10.1002/ijc.32199 – volume: 202 start-page: 484 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0245 article-title: Association between inflammatory potential of diet and bladder cancer risk: results of 3 United States prospective cohort studies publication-title: J Urol doi: 10.1097/JU.0000000000000279 – volume: 45 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0560 article-title: Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients publication-title: Clin Res Hepatol Gastroenterol doi: 10.1016/j.clinre.2020.07.019 – volume: 79 start-page: 82 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0015 article-title: European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines publication-title: Eur Urol doi: 10.1016/j.eururo.2020.03.055 – volume: 74 start-page: 784 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0055 article-title: Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018 publication-title: Eur Urol doi: 10.1016/j.eururo.2018.09.001 – volume: 110 start-page: 722 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0320 article-title: Trends in socio-economic inequalities in bladder cancer incidence in Canada: 1992–2010 publication-title: Can J Public Health doi: 10.17269/s41997-019-00227-y – volume: 1 start-page: 3 year: 2015 ident: 10.1016/j.eururo.2023.03.029_b0035 article-title: Global and regional patterns of tobacco smoking and tobacco control policies publication-title: Eur Urol Focus doi: 10.1016/j.euf.2014.10.001 – volume: 6 start-page: 61 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0575 article-title: Pioglitazone and risk of bladder cancer in type 2 diabetes mellitus patients: A systematic literature review and meta-analysis of observational studies using real-world data publication-title: Clin Epidemiol Global Health doi: 10.1016/j.cegh.2017.08.002 – ident: 10.1016/j.eururo.2023.03.029_b0270 – volume: 143 start-page: 3071 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0495 article-title: Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: a prospective pooled cohort study of 800,000 men and women publication-title: Int J Cancer doi: 10.1002/ijc.31597 – volume: 37 start-page: 639 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0310 article-title: Comprehensive analysis of genetic ancestry and its molecular correlates in cancer publication-title: Cancer Cell doi: 10.1016/j.ccell.2020.04.012 – volume: 23 start-page: 614 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0530 article-title: An updated meta-analysis on the risk of urologic cancer in patients with systemic lupus erythematosus publication-title: Arch Iran Med doi: 10.34172/aim.2020.72 – volume: 135 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0275 article-title: Diesel exhaust and bladder cancer risk by pathologic stage and grade subtypes publication-title: Environ Int doi: 10.1016/j.envint.2019.105346 – volume: 37 start-page: 1386 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0435 article-title: Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: A systematic review publication-title: Neurourol Urodyn doi: 10.1002/nau.23457 – volume: 44 start-page: e2022050 year: 2022 ident: 10.1016/j.eururo.2023.03.029_b0500 article-title: The relationship between metabolic syndrome and its components with bladder cancer: a systematic review and meta-analysis of cohort studies publication-title: Epidemiol Health doi: 10.4178/epih.e2022050 – volume: 75 start-page: 637 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0375 article-title: The microbiome and genitourinary cancer: a collaborative review publication-title: Eur Urol doi: 10.1016/j.eururo.2018.12.043 – volume: 46 start-page: 573 year: 2018 ident: 10.1016/j.eururo.2023.03.029_b0445 article-title: The risk of bladder cancer in patients with urinary calculi: a meta-analysis publication-title: Urolithiasis doi: 10.1007/s00240-017-1033-7 – volume: 54 start-page: 1169 year: 2022 ident: 10.1016/j.eururo.2023.03.029_b0125 article-title: Cigarette smoking and risk of bladder cancer: a dose-response meta-analysis publication-title: Int Urol Nephrol doi: 10.1007/s11255-022-03173-w – volume: 61 start-page: 2397 year: 2022 ident: 10.1016/j.eururo.2023.03.029_b0255 article-title: Dietary B group vitamin intake and the bladder cancer risk: a pooled analysis of prospective cohort studies publication-title: Eur J Nutr doi: 10.1007/s00394-022-02805-2 – volume: 81 start-page: 466 year: 2022 ident: 10.1016/j.eururo.2023.03.029_b0480 article-title: Genomic features of muscle-invasive bladder cancer arising after prostate radiotherapy publication-title: Eur Urol doi: 10.1016/j.eururo.2021.12.004 – volume: 71 start-page: 209 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0070 article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin – volume: 78 start-page: 893 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0315 article-title: Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita publication-title: Eur Urol doi: 10.1016/j.eururo.2020.09.006 – volume: 120 start-page: 571 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0330 article-title: Physical activity and subsequent risk of kidney, bladder and upper urinary tract cancer in the Japanese population: the Japan Public Health Centre-based Prospective Study publication-title: Br J Cancer doi: 10.1038/s41416-019-0392-y – volume: 23 start-page: 971 year: 2020 ident: 10.1016/j.eururo.2023.03.029_b0625 article-title: Clinical significance of 5-alpha reductase inhibitor and androgen deprivation therapy in bladder cancer incidence, recurrence, and survival: a meta-analysis and systemic review publication-title: Aging Male doi: 10.1080/13685538.2019.1646238 – volume: 145 start-page: 894 year: 2019 ident: 10.1016/j.eururo.2023.03.029_b0285 article-title: Ambient air pollution and incident bladder cancer risk: updated analysis of the Spanish Bladder Cancer Study publication-title: Int J Cancer doi: 10.1002/ijc.32136 – volume: 6 year: 2021 ident: 10.1016/j.eururo.2023.03.029_b0085 article-title: Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease study 2019 publication-title: BMJ Glob Health doi: 10.1136/bmjgh-2020-004128 – volume: 28 start-page: 2333 year: 2022 ident: 10.1016/j.eururo.2023.03.029_b0345 article-title: Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome publication-title: Nat Med doi: 10.1038/s41591-022-02014-8 – ident: 10.1016/j.eururo.2023.03.029_b0415 |
| SSID | ssj0003593 |
| Score | 2.7301862 |
| SecondaryResourceType | review_article |
| Snippet | Bladder cancer is a significant global health problem. Smoking and specific occupational exposures are the most established risk factors. There is emerging... Bladder cancer (BC) is common worldwide and poses a significant public health challenge. External risk factors and the wider exposome (totality of exposure... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 176 |
| SubjectTerms | Bladder cancer Epidemiology Humans Incidence Occupational Exposure - adverse effects Prevalence Risk Factors Smoking - adverse effects Smoking - epidemiology Tobacco Smoking Urinary Bladder Neoplasms - epidemiology Urinary Bladder Neoplasms - etiology Vehicle Emissions |
| Title | Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0302283823027070 https://dx.doi.org/10.1016/j.eururo.2023.03.029 https://www.ncbi.nlm.nih.gov/pubmed/37198015 https://www.proquest.com/docview/2815248101 |
| Volume | 84 |
| WOSCitedRecordID | wos001043019600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1873-7560 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0003593 issn: 0302-2838 databaseCode: AIEXJ dateStart: 20020101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9swFBZrO0pfxu7rLkWDvRWPxLIsaW9pSVm7rYyug7wZ68bStU7IpfTn78i6ONCFdg-D4ATbsiN9n4-Ojs8FoQ-Scim1VVkpjc5ASpYZ19ZmxiiqKSuksW3Vkq_s9JSPRuJ7cMict-UEWNPwmxsx_a9Qwz4A24XO_gPc6aKwA34D6LAF2GF7L-CHXc3X9u35waUTLrP9Q4evcz7fd7XMfUT6jy6P81mKYTlz3uZHvg7PXw338L1qiz9ZSumBP4al96_xVTLcBlO06Rh4sPxdX499HJoLye7MAc6QmByGg-02WCNyknzhYDLxEpQzkjHqiwREEeurwAUq5Svysu-Lv9yS496kcOGSX0KfPro7tblovXVkBcXpVQsjYX0Bcy3tZrXkaxgPbaCtnFEBkm9rcDwcnaT5mlBBYlBl6_l3-6Y7aDteZp3-sm590uop54_Ro7DAwANPjCfogWmeou1vwYXiGfqyyg88sTjwA3t-4HGD3V_6hAe4Ywf27HCnO3bgwI7n6OfR8PzwcxYqamSqKPuLDNaWVlgjijzXlJfSam1BYWYlpQZGQeelAqWpRyQjRjDRq23flJpbmSumDVPkBdpsJo15hXAhCJcGtOfC1rDEJ7Kn6lJRJcu-y0IodhGJ41SpkG7eVT25rKJf4UXlB7pyvap68MmhVZZaTX26lTvOpxGCKoYSw-RXAY_uaMdSu6BqehXyHi3fR6QrkMTu9VrdmMlyXuUcdOHCJczbRS89BVIfInterz3yBu10z9NbtLmYLc079FBdL8bz2R7aYCO-F5j7B1IDrM4 |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiology+of+Bladder+Cancer+in+2023%3A+A+Systematic+Review+of+Risk+Factors&rft.jtitle=European+urology&rft.au=Jubber%2C+Ibrahim&rft.au=Ong%2C+Sean&rft.au=Bukavina%2C+Laura&rft.au=Black%2C+Peter+C&rft.date=2023-08-01&rft.eissn=1873-7560&rft.volume=84&rft.issue=2&rft.spage=176&rft_id=info:doi/10.1016%2Fj.eururo.2023.03.029&rft_id=info%3Apmid%2F37198015&rft.externalDocID=37198015 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0302-2838&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0302-2838&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0302-2838&client=summon |